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ABSTRACT
OF MICE AND SIGMA:
CONFERRED ANTIBIOTIC RESISTANCE IN THE
SALMONELLA ENTERICA SEROVAR TYPHIMURIUM MURINE MODEL

Rena Margaret Wallen
April 6, 2012
Salmonella enterica serovar Typhimurium is an enteric pathogen capable of infecting

a wide range of hosts. The manner in which this pathogen is able to interact with its
host is difficult to define, as is the case with most microbes. Through the use of
alternate sigma factors and other regulatory processes, S. Typhimurium is able to
invade host cells to establish systemic infections, and survive the assaults of the host
immune system. While most strains of S. Typhimurium are typically ampicillin
sensitive, within the host, survival inside host cells may provide an escape from
many antibiotics. Previous research demonstrated that co-culture with ampicillin
resistant strains of Escherichia coli is able to provide protection for sensitive S.
Typhimurium. The current study was an attempt to model this relationship within
the host. While S. Typhimurium was able to grow within murine hosts in the
presence of ampicillin, it is unclear whether this resistance is from coinfection with
a resistant strain of E. coli or from the ability of S. Typhimurium to avoid destruction
by antibiotics by invading host cells.
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CHAPTER 1
GENERAL INFORMATION
The emergence of antibiotic resistance in bacteria has caused many concerns
in the sanitation and health care industries. Most of this resistance seems to be the
result of transfer of genetic information between the same or closely related species.
However, this may not be the only way that antibiotic susceptible bacteria are able
to survive in the presence of bactericidal agents. Previous work has demonstrated
that bacteria that do not possess genetic information to produce enzymes conferring
resistance may be able to survive in the presence of other bacteria that do, even in
the presence of lethal dosages of antibiotics.
The specific antibiotic examined in these studies was ampicillin. Ampicillin is
a member of the p-Iactam family of antibiotics that includes amoxicillin and
penicillin. This family of antibiotics binds to and prevents the action of
transpeptidases that are important in constructing the peptidoglycan layer of the
bacterial cell well [1]. Blocking the activity of these transpeptidases renders the
bacterium unable to complete its cell wall and results in a loss of osmotic stability
and eventually cell death [1]. Sensitivity to this mechanism of action requires the
bacteria to be growing and making new cell wall elements. p-Iactam antibiotics are
therefore only effective against dividing cells, i.e., not those in stationary phase that
are not rearranging and reforming their cell walls.
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One way that bacteria are able to survive ampicillin treatment typically is by
producing the enzyme

~-lactamase

which modifies with the antibiotic's physical

structure and activity.

~-lactamase

cleaves the functional ring of ~-lactam

antibiotics, rendering them unable to bind to transpeptidases and blocking the
activity of the antibiotic. Because this mode of resistance is the production of an
enzyme that breaks down the antibiotic, it has been theorized that bacteria
producing

~-lactamase

may be able to provide some protection for typically

sensitive strains colonizing the same system. If this is the case, bacteria may be able
to survive antibiotic treatment without acquiring the ability to produce the enzyme.
In vitro studies co-culturing ampicillin resistant strains of bacteria with

ampicillin sensitive strains in the presence of the drug has produced interesting
results. In these studies, the

~-lactamase

gene was carried on a plasmid by

Escherichia coli. Multiple strains of ampicillin-resistant E. coli were engineered, each

producing ~-lactamase from a plasmid introduced into the cell and each
demonstrating resistance to high levels of ampicillin treatment. All of the resistant
strains in these studies contained the biaTEMl gene, encoding a class A TEM-l
lactamase [2]. Two types of strains were engineered, one in which the

~

~-lactamase

remained inside the bacterial cell producing it and the other that was able to release
the enzyme into the extracellular space. Six times more

~-lactamase

was found in

the media where growing cells releasing the enzyme than in those engineered to
keep it inside [3]. Carrying the plasmid did result in some cost to the bacteria [2], as
non-plasmid bearing bacteria of the same species were able to outcompete plasmid
bearing bacteria in the absence of ampicillin [3].
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However, in the presence of ampicillin, despite the metabolic cost, carrying
the plasmid containing ~-lactamase produced a selective advantage. Moreover, in
some cases, typically sensitive bacteria were able to survive when grown in culture
with their resistant cousins. The same phenomenon was not observed equally
amongst the two different types of strains. When co-cultured with the strain that
kept the

~-lactamase

within the producing cell, sensitive E.coli were unable to

survive; however, in the presence of cells secreting

~-lactamase

into the

extracellular space, sensitive E.coli were able to survive, albeit at lower level than
their resistant benefactors [2]. In a similar study, sensitive E. coli were able to
survive at only about 3% of the original population when grown with E. coli
releasing

~-lactamase

[4]. A considerable amount of ~-lactamase was found in the

media where these resistant bacteria had grown [3].

E. coli tend to be commensal species so antibiotic resistance does not present
health complications to host organisms. However, species like Salmonella enterica

serovar Typhimurium, which are typically pathogenic, may be offered the same
protection as their commensal relatives in the presence of antibiotic resistant
bacteria. In fact, S. typhimurium was observed to survive despite ampicillin
treatment in the presence of E. coli releasing

~-lactamase.

After an initial period of

apparent elimination of S. Typhimurium lasting about 12 hours, survival ofthe
pathogen was observed after 24 hours grown with

~-lactamase

producing E. coli

and continued to increase through the duration of the experiment [4]. Additionally,
unlike the E. coli that were not protected by strains retaining

~-lactamase

inside the

producing cell, S. typhimurium when competed against such resistant E. coli strains,
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was, able to survive at approximately the same rate as it was able to persist when

~

lactamase was released into the extracellular space [4]. Further analysis ofthese
competitions revealed that no transfer of genetic information had occurred nor did
the resistant E. coli and sensitive S. typhimurium have to be grown in physical
contact for the protection to be provided [4]. Moreover, while the
activity in this strain was confined to the producing cell,

~-lactamase

~-lactamase

was found

within the supernatant, indicating cell lysis [4], potentially due to S. typhimurium
activity against other bacterial strains.
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CHAPTER 2
IN VIVO EXPERIMENTS WITH SELECTED BACTERIAL STRAINS AND AMPICILLIN

1. Introduction
The current research is an attempt to model the competition between
ampicillin resistant and sensitive strains within a host organism, specifically the
mouse. Bacterial strains were introduced and monitored in the presence of
antibiotic treatment to determine if similar results [4] could be observed within a
live host. In vivo modeling provides environments not encountered within an in
vitro setting. Inside a host, bacteria interact with host cells and any other bacteria

present within the system. The microorganisms must compete for nutrients with
the host as well as other bacteria, and the availability of nutrients is limited by the
food intake of the host. In the case of the enteric bacteria, consumed food moving
through the gastrointestinal tract presents a dynamic environment through which
bacteria must negotiate. An attempt to model bacterial competitions within a host
must consider these varied conditions.

2. Materials and Methods
2.1 Plasmids and Host Bacteria
In these studies, E. coli strains were competed against other strains of E. coli
and against S. Typhimurium, specifically strain 14028S. This S. Typhimurium strain
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has a functional type three secretion system, necessary for establishing systemic
infections, but does not carry any genetic antibiotic resistance.
Three types of plasm ids were used to model bacterial competitions in mice,
the same three that had been used in previous studies leading to the in vivo model.
All of these plasmids were derivatives of pCR2.1 TO PO (Invitrogen, Carlsbad, CA)
and were nonconjugative plasmids [3]. Two of these plasm ids were constructed by
investigators in previous research leading to this work. The SAR plasmid, an
acronym for Shared Antibiotic Resistance, carried a copy of the blaTEM-l gene
attached to the 5' end of a region of DNA containing ompA and Ipp [2]. Along with
OmpA and Lpp,

~-lactamase

produced from the gene on this SAR plasmid is carried

to the outer membrane but in theory remains attached to the cell, extending into the
extracellular space where it is able to destroy ampicillin in the vicinity [2]. As noted
earlier, because a substantial amount of ~-lactamase was found in the supernatant
in which the bacterial strains were grown [3], it is likely that some portion of the

~

lactamase is released from the cell, broken from its tether to the outermembrane, or
released into the extracellular milieu upon lysis of the cell.
The SLAR plasmid (Self-Limited Antibiotic Resistant) carries the same blaTEM1

gene but a mutation in the coding region for the signal peptide prevents the

protein from being transported completely into the peri plasm [2]. As such, the
protein is attached to the cytoplasmic membrane facing the periplasm, and in theory
should only provide protection for the cell expressing the gene [2]. Both SLAR and
SAR plasmids were introduced into E. coli 6925, a typical strain used in lab work (F-,
relAl, rpsL254(strR), spoT1, metBl, LacZ+, E. coli Stock Center, CGSC, Yale
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University). Without the plasmid, E. coli 6925 is sensitive to ampicillin treatment.
These strains will be referred to as (pSAR) and (pSLAR) respectively.
A third plasmid, (pBR322), is a commonly used CoIE1-derivative bearing the
b/aTEM-l gene, as well as a tetracycline resistance gene [5]. B-Iactamase produced

from this cell also remains inside the bacterial cell, not released to the extracellular
milieu. The plasmid was originally in an E. coli Lu53 background (F-, /acI22 (LacI-),
proC43, D(kdpC-kdpA)18, LAM-, /ysA28, rpsL139(strR),g/pR7(glpn)?, g/pR8(glpc),

rha-4, thi-l, E. coli Stock Center, CGSC, Yale University). There did not appear to be
any differences between the 6925 and Lu53 strains that would influence the
outcome of this study. However, later this plasmid was also introduced into the E.
coli 6925 background to ensure that any differences observed were due to the

plasmids and the resulting difference in

~-lactamase

localization, not the

background strain.

2.2 Mouse Strains
Inadvertently, two different strains of mice were used. Originally, the
protocol was designed to use only one as the model organism, the 129xl/svJ strain
from Jackson Laboratories. This mice strain is Nrampl

+/+ [6]. This gene has been

found to be essential in preventing the development of systemic infections in mice.
It encodes an integral membrane protein that is recruited to the phagosome
containing S. Typhimurium within macrophages [7]. This strain of mice will develop
an acute infection but it will not become systemic because the pathogen is not able
to travel inside cells of the immune system to be transported to other parts of the
body.
7
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Due to a clerical error, a second strain of mice was also used, DBA/2J from
Jackson Laboratories as well. Despite this error, fortunately the later strain had
been used also for S. Typhimurium studies previously. While far more susceptible
than 129xlfsvJ mice in terms of systemic infections, potentially due to a different
genotype for the two Nrampl alleles, these mice develop infections that show
intermediate symptoms between extremely susceptible mice strains, like BALB/c
and resistant strains like 129xl/svJ [8], indicating that they do not typically succumb
quickly to acute infections but succumb quickly to systemic infections when they
develop.
Mice were housed in cohorts of 3 to 4 and each cage was treated as one
experimental unit. Fecal samples were collected daily from the bottom of the cage.
Cage bottoms were then cleaned, sterilized, and returned to the cage. When
innoculations were done or treatment was changed (ampicillin to no ampicillin in
drinking water, or vice versa), mice were moved to clean and sterile cages with
fresh food and water to avoid reexposure from the cage, food, or water.
All mice were handled and cared for in the manner dictated by the
Institutional Animal Care and Use Committee in accordance with IACUC protocol
#10019.
2.3 Innoculation with Bacterial Strains
Before inoculation with a given bacterial strain, all mice were treated with
500 Ilg/mL streptomycin, either in sterilized drinking water or by gavage of 100 ilL
ofthe same concentration, to reduce native microbiota and thereby provide a
suitable environment for colonization with the administered bacteria. Drinking
8
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bottles were sterilized before being filled with streptomycin-containing drinking
water. Fecal samples were collected daily and plated on Hektoen agar plates to
asses gut microbiota. Streptomycin was administered fresh daily when
administered in drinking water.
Each bacterial strain was streaked from frozen stock onto Hektoen agar
plates. For strains bearing the plasmid, over night growth was done on plates
containing ampicillin at 100 Ilg/mL. The following day, strains were inoculated into
and grown overnight in Lysogeny broth (LB). If the strain was supposed to carry a
plasmid rendering it resistant to ampicillin, the LB was supplemented with
ampicillin at 100 Ilg/mL to ensure the bacteria administered to the mice contained
the plasmid. Samples (2 mL) from the overnight cultures were spun at 20,000 rpm
for 10 minutes. The supernatant was removed and the pellets were resuspended in
667 ilL phosphate buffered saline (PBS) (Invitrogen). From this solution, 100 ilL
was administered to each mouse by gavage.
Prior to gavage, food and water were removed from the mice for 4 hours to
ensure no regurgitation during the procedure. A different sterilized gavage needle
was used for each cohort. Mice were then monitored for several hours following the
procedure to ensure that esophageal tearing had not occurred. For ampicillin
resistant strains, mice were pretreated with ampicillin for at least a day prior to
infection. The metabolic cost for the bacteria of carrying the plasmid made it
difficult to colonize these strains without establishing an artificial selective
advantage.

9

2.4 Preparation and Administration of Ampicillin
Ampicillin was prepared in a concentrated stock, frozen, then thawed and
diluted to the appropriate concentration for both agar plates and administration to
the animals. Individual aliquots of the concentrated solution were only thawed once
to reduce ampicillin degradation due to freezing and thawing repeatedly.
All Hektoen plates with ampicillin contained the antibiotic at a concentration
of 100 Ilg/mL. For administration to the mouse cohorts in drinking water,
ampicillin from the concentrated stock was diluted into sterilized water and given to
the mice in drinking bottles. In most cases, ampicillin was administered at 200
Ilg/mL. In other cases, the dosage was increased to determine if higher dosage
would result in complete clearing of infection. These bottles were cleaned and
sterilized following streptomycin treatment. Ampicillin in drinking water was
replenished every 24 hours.
2.5 Sample Collection and Preparation
Fecal samples were collected daily using tweezers to gather pellets from the
bottom of specially designed cages with a mesh wire to catch pellets. The freshest
samples were collected to ensure a sample most reflective of the current state in the
mouse gut and because they were the easiest samples to process.
Using an adapted protocol [9], fecal samples were weighed prior to
processing. Samples were processed fresh or frozen and no difference existed in the
data produced comparing frozen vs. fresh fecal samples(data not shown). Into each
collection tube, 1000 ilL of sterilized dHzO was added. The pellets were broken up
using a small plastic pestle with a blunt end and then vortexed vigorously to ensure
10

the pellets were as macerated as possible. These samples were then centrifuged for
10 minutes at 800 rpm. The supernatant was removed and transferred to clean
micro centrifuge tubes. The supernatant was then centrifuged for 5 minutes at 6000
rpm. The supernatant from this centrifugation was then removed and the pellet
containing bacteria was resuspended in 200 ilL sterile dHzO. This sample was either
used to plate undiluted samples or to serially dilute samples so that it was possible
to count colony forming units (CFUs). Dilutions were plated until CFUs on one plate
were between 20 and 200 colonies to ensure accurate count. All samples were
plated on Hektoen agar plates, with ampicillin (100 Ilg/mL) to determine ifthe
strains growing were ampicillin resistant or without antibiotic.
Plated samples were grown overnight at 37°C and CFUs counted following 24
hours of growth. In some cases, samples were retained and if plated dilutions could
not be counted accurately, further serial dilutions were performed and plated.

3. Results
3.1 S. Typhimurium grew with resistant strains of E. coli in presence of ampicillin.
S. Typhimurium was able to colonize DBA/2J mice first cleared of gut flora by

gavage with 100 ilL of 500 Ilg/ mL streptomycin and then inoculated with E. coli
strains carrying plasmids rendering them resistant to the bactericidal activity of
ampicillin. E. coli strains carrying pBR322 or pSLAR plasm ids were first inoculated
into the mouse. Once the colonization of these strains was verified, ampicillin
treatments at 200 Ilg/mL were begun, and the colonies obtained from fecal samples
were able to persist indicating that the inoculum had contained plasmid-bearing
bacteria. After ampicillin was removed, each cohort was then inoculated with S.
11

Typhimurium, which was allowed to colonize for several days. Summarily,
ampicillin treatment was restarted to determine if S. Typhimurium was able to
persist. After 4 days (96 hours) of growth treatment with ampicillin when S.
Typhimurium was grown alone, the bacteria were not detectable from fecal samples
(data not shown).
When grown the E. coli Lu53 (pBR322), 24 hours after treatment with
ampicillin, S. Typhimurium dropped to an almost undetectable level. However, after
48 hours, the pathogen had begun to recolonize and grew steadily over the next few
days (Figure 1a). Prior to treatment with ampicillin, S. Typhimurium grew at
approximately 3.99x104 CFU per milligram fecal sample, although it did not displace
Lu53 (pBR322) and they were growing in an essentially 50:50 ratio within the
mouse gut based on fecal samples. 24 hours after the ampicillin regiment was
begun, the S. Typhimurium detectable growth dropped to 409 CFU per milligram
fecal sample, a reduction of 98.98%. At the peak of growth during ampicillin
treatment, when grown with Lu53 (pBR322), S. Typhimurium was able to return to
a level of 8.8x10 3 CFU per milligram fecal sample, 22% ofthe original growth
without ampicillin present. This pattern was similar to results observed in a similar
in vitro model (Perlin 2009), with an initial period of S. Typhimurium near
disappearance followed by recolonization.
When grown with E. coli 6925 (pSLAR) strain, different results for S.
Typhimurium were observed. When initially grown with E. coli 6925 (pSLAR)
without ampicillin, S. Typhimurium grew at the rate of 3.88x10 4, a comparable rate
as that observed with Lu53 (pBR322). However, after 24 hours of treatment with
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ampicillin, the observable number of CFUs for S. Typhimurium remained high,
roughly the same for the first 24 hours and then dropping off to undetectable after
48 hours. After 72 hours, S. Typhimurium began to show signs of recolonization,
but only at very low levels, the maximum CFU count being 3.07x103 per milligram
sample, 7.9% ofthe growth observed without ampicillin.

3.2 S. Typhimurium was not cleared from gut during ampicillin treatment
A replication of the previous study was again attempted in DBA/2J mice. In
this case, streptomycin was administered at a concentration of 500 Ilg/mL in
drinking water, rather than by gavage. Clearing of the gut was observed before
bacterial inoculation occurred. Inoculation with bacterial strains was quickly
followed by treatment with ampicillin for cohorts infected with resistant strains to
assist in colonization of the gut. Once the E. coli infection was confirmed, S.
Typhimurium 14028 was added to all four cohorts.
When grown with E. coli 6925 not carrying a plasmid and therefore sensitive
to ampicillin, S. Typhimurium completely displaced the well-established E. coli
within 48 hours. Unexpectedly, when ampicillin treatment began at 200 Ilg/mL,
while clearance had been observed previously when S. Typhimurium growing alone,
the bacteria survived at a low rate throughout 11 days of treatment (Figure 2a),
reaching a maximum of 754 CFU per milligram fecal sample. After an initial period
of apparent clearing, S. Typhimurium was able to recolonize despite continued
ampicillin treatment.
When grown with E. coli 6925 (pBR322), S. Typhimurium was not able to
displace the E. coli 6925 (pBR322) but grew with it. With ampicillin treatment,
13
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Figure 1: The return of S. Typhimurium following ampicillin treatment when grown
with a) E. coli Lu53 (pBR322) and b) E. coli 6925 (pSLAR).

S. Typhimurium was able to persist but at much lower levels than observed with E.
coli 6925 (Figure 2b), reaching only a maximum of 66 CFU per milligram fecal

sample. After 9 days of ampicillin treatment, no colonies of S. Typhimurium were
detected in fecal samples from this cohort with continued antibiotic administration.
When grown with E. coli 6925 (pSAR), again S. Typhimurium was not able to
displace the originally established bacteria but instead grew with it. Upon initiation
of ampicillin treatment, after a few days of what seemed to be elimination of the
pathogen, S. Typhimurium returned and was observed at a level higher than
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observed with the E. coli 6925 cohort, reaching a maxium of 1.5x10 3 CFU per
milligram fecal sample (Figure 2c), although the concentration appeared to drop
after 10 days of treatment.
When grown with E. coli 6925 (pSLAR), S. Typhimurium grew along with the
commensal species until the introduction of ampicillin. Upon initiation of the
ampicillin regiment, the S. Typhimurium seemed to be eliminated. However,8 days
into treatment, S. Typhimurium colonization was again observed at reasonably high
levels, 727 CFU per milligram fecal sample (Figure 2d). This level of colonization
was, however, comparable to levels S. Typhimurium was able to achieve when
grown without a protective resistant E. coli strain. On day 11 of ampicillin
treatment, all cohorts showed complete clearing of S. Typhimurium. Unlike the
other three cohorts, this was the only day of total clearing observed for this cohort
from fecal samples.
After 11 days of treatment with ampicillin at 200
increased to 400

~g/mL

~g/mL,

the dosage was

to determine if the S. Typhimurium could be cleared

completely and for multiple days at a higher dosage. For the two days this level of
ampicillin treatment continued, no S. Typhimurium CFUs were observed in the fecal
samples from all four cohorts. After two days of treatment with ampicillin at 400
~g/mL

in drinking water, ampicillin treatment was removed from all four cohorts to

determine if S. Typhimurium was able to recolonize. One day following the removal
of ampicillin treatment, no CFUs appeared in any of the four cohorts. However, 48
hours following the removal of ampicillin treatment all cages had returned to levels
of S. Typhimurium colonization similar to those prior to initial treatment (Figure 3).
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Thus, in only 48 hours without treatment, the few bacterial cells able to survive the
increased level of antibiotic treatment, S. Typhimurium was able to reestablish
colonization of the gut detectable in fecal samples as if treatment with ampicillin
had never occurred.
Attempts to use a similar infection model in 129xl/svJ mice failed, primarily
due to the lack of establishment of the desired bacteria. The guts were cleared by
the streptomycin but verifying the establishment of the inoculated strains was never
determined from fecal samples.
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Figure 2: Salmonella Typhimurium CFUs observed in cohorts treated with
ampicillin (200 Ilg/mL) for a period of 11 days grown with a) E. coli 6925, b) E. coli
6925 (pBR322), c) E. coli 6925 (pSAR), and d) E. coli 6925 (pSLAR).
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Figure 3: S. Typhimurium was detectable again in the fecal samples from all four
cohorts following the removal of ampicillin.
3.3 Sensitive E. coli strains are protected when grown with resistant strains
Using DBA/2J mice, three cohorts originally inoculated with each of the three
resistant strains of E. coli, E. coli (pBR322), E. coli (pSAR), and E. coli (pSLAR), while
being treated with ampicillin to provide a selective pressure for the strains to retain
their plasmids. After confirmation that the inoculated strains were established,
ampicillin treatment was removed and E. coli 6925 was added. After giving the
bacteria 24 hours to colonize the gut in absence of antibiotic treatment, ampicillin
was returned to the cohorts in drinking water at 200 Ilg/mL.
Because it was impossible on Hektoen plates to distinguish E. coli carrying
the plasmid from plasmid-free cells, replicating plating was done to determine what
portion of CFUs represented those with or without the plasmid. Cells from each
sample were diluted and plated until individual cells could be counted. Individual
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colonies were then streaked onto drug-free plates. The same colonies were then
replica streaked on agar containing ampicillin to determine if any non-plasmid
carrying colonies survived treatment with ampicillin. Since plasmid loss is possible
given the metabolic cost of carrying it, it is not beyond the realm of possibility that
some of the sensitive colonies are the result of cells losing plasm ids. However, if
these bacteria were still able to survive in the presence of ampicillin, they would still
be considered protected.
After 8 days of treatment, ampicillin sensitive E. coli were able to survive in
the presence of E. coli (pSAR) and E. coli (pSLAR). In the presence of E. coli 6925
(pBR322), no sensitive E. coli were observed to have survive (data not shown).
When grown with E. coli 6925 (pSAR), an average of 31. 7% of cells screened were
sensitive over three days of treatment (Figure 4). In the cohort originally inoculated
with E. coli (pSAR), all of the colonies screened were sensitive to ampicillin when
streaked on drug plates.
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%

• Resistant

o Sensitive

8

10
9
Days after Ampicillin Treatment

Figure 4: Percentage of sensitive E. coli surviving treatment with ampicillin when
grown with E. coli (pSAR).
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Attempts to replicate this model in 129xljsvI mice also failed due to similar
problems with establishing administered bacteria strains as discussed above.
Streptomycin pretreatment followed by inoculation resulted in clear fecal samples.

4. Discussion
Previous in vitro models had demonstrated that ampicillin-resistant E. coli
strains were able to provide protection for sensitive strains of both E. coli and S.
Typhimurium when grown together in media as bacteria cultures. This protection
was a function of the ability of the

~-lactamase

produced by ampicillin-resistant

strains to destroy enough ampicillin to allow these sensitive strains to grow without
acquiring the ability to produce the enzyme themselves or other resistance
mutations.
When an in vivo model was attempted using mice, mixed results were
observed. In the mouse, similar protective effects were observed for sensitive
strains of E. coli, similar to results from in vitro studies [2], [3]. Because these
sensitive strains were cleared easily when grown alone and treated with ampicillin,
it is likely that this model did demonstrate the ability of resistant E. coli to protect
their sensitive relatives. It was impossible to determine if the sensitive strains were
actually the E. coli 6925 introduced or members of the originally resistant strain
who had lost their plasm ids, so called cheaters [2], but it was clear that sensitive and
resistant strains of E. coli were growing within the same mouse gut environment
during ampicillin treatment.
The proportion of sensitive to resistant E. coli growing together was
consistent with what was expected given the location of the
19

~-lactamase

within the

resistant cells. E. coli (pBR322) provided no detectable protection for sensitive E.

coli, consistent with the ability to maintain p-Iactamase inside the resistant cell. E.
coli 6925 (pSAR) provided almost complete protection for sensitive bacteria, with
the majority of the bacteria persisting in the mouse after several days of treatment
with ampicillin being sensitive. E. coli 6925 (pSLAR) produced intermediate results,
as expected, since in this case, the p-Iactamase protein is tethered to the peri plasmic
membrane and is acting upon ampicillin but not in the extracellular space. A
substantial proportion of sensitive E. coli were able to survive despite treatment
with a typically lethal dosage of ampicillin.
However, S. Typhimurium presented the interesting case. At first it appeared
that resistant E. coli were able to offer protection to ampicillin sensitive S.
Typhimurium when grown inside the mouse simultaneously, similar to results
previously observed [4]. However, it later became apparent that the dosage of
ampicillin being administered was not sufficient to eliminate the S. Typhimurium
infection alone. As such, it was impossible to determine if protection was actually
occurring or if the S. Typhimurium infection was able to sustain because the dosage
of ampicillin was not sufficient to eliminate the pathogen. It was apparent that the
bacteria were not eliminated because upon the removal of ampicillin treatment, S.
Typhimurium was able to recolonize the mouse gut.
These inconsistent results prompted further investigation into the
pharmokinetics of ampicillin, particularly the ampicillin as used in the manner
prepared for these in vitro studies. Experiments were also designed to determine
the effect of pH and temperature inside the mouse on the effectiveness of ampicillin
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as an antibacterial agent. Moreover, it was pertinent to determine at what dosage of
ampicillin S. Typhimurium was no longer able to survive inside the mouse gut when
grown without ampicillin-resistant E. coli.
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CHAPTER 3
IN VITRO STUDIES OF THE PHARMAKINETICS OF AMPICILLIN AND IN VIVO

ATTEMPTS TO CLEARS. TYPHIMURIUM INFECTION

1. Introduction
Ampicillin has been widely used to treat both Gram negative and Gram
positive bacterial infections. However, even among the family of ~-lactams, it is not
the most effective. While other

~-lactams

like amoxicillin showed a measurable

therapeutic effect at dosages as low as 20 mg/kg, ampicillin only had limited
effectiveness at 200 mg/kg [10]. In humans, ampicillin has a low oral
bioavailability, approximately 30 to 40% [11]. The serum half-life of ampicillin in
humans is 1.8 hours [12], indicating that it is quickly degraded at physiological
conditions. This may have contributed to results observed previously in in vivo
models of S. Typhimurium and E. coli infections.
For ampicillin like other antibiotic drugs to be effective, it must be able to
penetrate the tissue in which the bacteria is found or survive the pH of the
gastrointestinal tract to reach bacteria growing in the luminal space of the small
intestines [12]. The low bioavailability of ampicillin is a product of its
hydrophilicity and mechanisms of absorption when administered orally [11]. There
is some evidence that ability to enter into infected tissues is decreased at decreasing
pH, such as is found in the gastrointestinal tract [11]. If the ampicillin is able to
survive the low pH conditions of the stomach, the pH within the intestine is near
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neutral and entrance may be easier, although the effective dosage will be
dramatically reduced. Even once the antibiotic survives physiological conditions to
reach the site of infection, it still must be able to interact with the bacteria in a
specific way to cause cell death. In the case of E. coli, ampicillin must traverse the
outer membrane to reach its target, which is typically done through general
diffusion porins within the bacterial cell [13].
In early murine models of S. Typhimurium infection, treatment of as.

Typhimurium infection for three days with subcutaneous injections of ampicillin at
a dosage of 64 mg/kg mouse weight prevented an increase of bacteria in the blood
and spleen but did not eliminate the infection [12]. In the same study, significant
decrease in bacterial load in the blood was found with dosages as low as 16 mg/kg
while reduction of mortality was observed at dosages greater than 64 mg/kg [12].
These results indicate that ampicillin may be able to control the increase of as.
typhimuium infection but not necessarily eliminate it completely. Moreover, these

measures are of a systemic infection, not infection only within the gastrointestinal
tract, and ampicillin treatment may be different within this system.
Our previous attempts to model the ability of ampicillin resistant E. coli to
provide protection for typically sensitive S. Typhimurium may have been
complicated by the inability of ampicillin to effectively eliminate the pathogen
infection. As such, the protection observed may be a result of ineffective dosage
rather than the

~-lactamase

produced by the resistant strains eliminating enough

ampicillin within the system to allow some of the sensitive bacteria to survive. The
following set of experiments was a means of examining both the pharmokinetics of
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ampicillin as it was prepared for the murine model in Chapter 2 and attempting to
find the dosage at which the S. Typhimurium infection could be eliminated.
2. Materials and Methods

2.1 Plasmids and Host Bacteria
E. coli and S. Typhimurium strains were the same as used previously: E. coli
6925, E. coli 6925 (pSAR), E. coli 6925 (pSLAR), and S. Typhimurium. Before each

experiment, strains were streaked from pure frozen stock. LB broth was then
inoculated with the bacterial strains and grown overnight.
For in vitro work, overnight cultures were diluted by 100 and then grown
until the cell densities measured spectophotometrically indicated logarithmic
growth.
2.2 Mouse Strains
For in vivo models, both mouse strains previously described (Chapter 2)
were used: DBA/2J and 129xlfsvJ. In vivo murine models were an attempt to
determine the dosage of ampicillin to clear S. Typhimurium infection. Mice lived in
cohorts of two.
2.3 Innoculation with Bacterial Strains
Before inoculation, mice were again treated with 500 Ilg/mL streptomycin in
drinking water from sterilized bottles to render the gut clear for establishing S.
Typhimurium infection. Food and water were removed for 4 hours prior to
inoculation. Each mouse was administered by gavage 100 Ilg of bacterial
suspension prepared as described previously. Mice were again monitored for
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several hours following the procedure to determine if esophageal tearing had
occurred during gavage.
2.4 Preparation and Administration of Ampicillin
Ampicillin was prepared as before, diluted from a concentrated stock for
each administration to the mice cohorts. Five cohorts of mice were used, each
receiving a different dosage of ampicillin, either in a single dosage or in drinking
water: 200
~L

of 500

200

~g/mL

~g/mL

~g/mL

as previously used, 400

~g/mL,

600

ampicillin, and a single bolus of 100

~g/mL,

~L

a single bolus of 100

of 500

~g/mL

followed by

in drinking water. For administration in drinking water, fresh

ampicillin was made daily.
2.5 Minimum Inhibitory Concentration of Ampicillin
Hektoen and LB agar plates were prepared containing decreasing
concentrations of ampicillin: 800,400,200, 100,50, 12.5,6.25,3,12, and 1.56
~g/mL.

All five strains of bacteria, E. coli 6925, E. coli 6925 (pSAR), E. coli 6925

(pSLAR), and S. Typhimurium, were grown to mid-logarithmic growth phase as
confirmed by optical density. 15

~L

of bacterial suspension was spotted onto each

plate and plates were grown for 24 hours, incubated at 3rc. Statistical analyses of
growth/inhibition were done using I-tailed t-tests.
2.6 Evaluation of Ampicillin Stability at different pH and Temperature
Ampicillin was prepared at a concentration of 200

~g/mL

and then subjected

to different conditions for 24 hours, with measurements taken ever 6 hours. These
conditions were meant to simulate those found within the mouse and during the
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administration of the drug as part ofthe experiment. As the ampicillin administered
to mouse cohorts was left at room temperature, degradation of ampicillin at room
temperature may have dramatically decreased. Ampicillin was left at room
temperature, as well as stored at 37°C at the approximate at a pH of 4, the
approximate pH of the murine and human stomach in a fasted condition; pH was
maintained at pH 4 in acetate buffer. Sterilized dH20 at room temperature and the
acetate buffering solution at 37°C were used as controls to determine if pH alone
had an effect on bacterial viability.
The pH of each solution was measured at 0 hours and again at 24 hours to
determine if the pH of any of the solutions changed over time. Samples were taken
every six hours and frozen until all samples had been collected. Discs made using a
standard hole punch from filter paper were impregnated with 10 ilL of each solution
and allowed to dry before being placed on bacterial plates.
Sensitive strains of bacterial, E. coli 6925 and s. typhimuium, and resistant E.
coli 6925 (pBR322) were grown in LB to mid-logarithmic phase as confirmed by

measuring optical density. 150 ilL of each bacterial suspension were spread onto LB
agar and Hektoen agar plates. Impregnated disks were placed on the plates and
plates were incubated for 24 hours at 37°C.
2.7 Measurement of bacterial sensitivity when grown in culture
Three strains of bacteria, one known to be ampicillin sensitive, E. coli 6925,
one known to be ampicillin resistant, E. coli 6925 (pBR322), and S. Typhimurium
were grown in LB overnight from pure frozen stock. After growing overnight, all
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three cultures were diluted by 100 fold into LB broth and grown to mid-logarithmic
phase, as measured spectophotometrically.
100 mL of LB broth containing ampicillin at 50, 100, and 200 Ilg/mL in 500
mL flasks were inoculated with 100 ILL of the bacterial suspension. Samples were
taken every 12 hours. Measurements of bacterial growth and/or survival were
made spectophotometrically and by plating.

2.8 Collection and Preparation of Fecal Samples
Fecal samples were collected daily and processed as described in Chapter 2.

3. Results
3.1 Temperature and pH affect bactericidal properties of ampicillin
For the control strain, resistant E. coli (pBR322), no difference was observed
in the inhibitory properties of ampicillin regardless of time, temperature, or pH at
which the ampicillin was stored for 24 hours; i.e., all measured zones of inhibition
were O. The pH ofthe ampicillin solution was 7.0 at 0 and 24 hours and the pH of
the buffered solution alone and containing ampicillin was 4.1 at 0 and 24 hours.
For sensitive E. coli 6925, when grown on Hektoen plates, no inhibitory
properties of sterilized water or the pH buffering system were observed. The zone
of inhibition around the impregnated disc was significantly smaller after 6 hours of
200 Ilg/mL ampicillin at room temperature than immediately after the ampicillin
was prepared (p < 0.05), and continued to decrease over the course of 24 hours,
indicating that the ampicillin was degrading at room temperature and therefore was
less able to eliminate the sensitive bacteria. When plated on LB agar, a significant
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difference was not observed from the initial zone of inhibition until the 24 hour
sample (p < 0.005), but differences at 12 and 18 hours showed trends toward
significance (p = 0.058 and p=0.018 respectively).
For ampicillin 200 Ilg/mL stored at 37°C and pH 4 to simulate physiological
conditions, the impregnated disks had significantly smaller zones of inhibition
around them for E. coli 6925 grown on Hektoen after 24 hours (p<.05), and though
not significant, a similar trend was observed after 18 hours (p = 0.18). When grown
on LB plates, no significant decrease in zone of inhibition was observed over 24
hours, potentially due to different agar properties.
For S. Typhimurium 14028S, no differences in zone of inhibition were
observed for 200 Ilg/mL at room temperature or stored at 37°C and pH when grown
on Hektoen. However, when grown on LB plates, after 12 hours, the zone of
inhibition around impregnated disks containing 200 Ilg/mL stored at room
temperature was significantly smaller (p<.Ol) and continued to get smaller over the
course of he 24 hour experiment. For the 200 Ilg/mL ampicillin stored at 37°C and
pH, a significantly smaller zone of inhibition was observed after 6 hours (p<0.05)
and over the 24 hour observation period, the observed zones of inhibition continued
to decrease.
The difference between the two sensitive strains may be a result of their
different sensitivities to ampicillin. Moreover, S. Typhimurium was at a higher
optical density (and therefore more cells were growing) at the time of plating than
either E. coli strain. Either way, it is clear that the bactericidal properties of
ampicillin decrease at room temperature and at physiological temperature and pH
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over 24 hours. As such, the effective dosage the mice were receiving was not
constant between changes of the ampicillin.
3.2 Salmonella demonstrates a range of sensitivities to ampicillin

When plated on Hektoen and LB plates containing various concentrations of
ampicillin, S. Typhimurium was for the most part eliminated at fairly low
concentrations but a few cells in each sample were able to persist across a range of
concentrations (Table 1).
Although most S. Typhimurium cells seem to be more sensitive to ampicillin
than E. coli 6925, individual bacterial colonies were observed growing at 4 times the
concentration that the original observed to be inhibitory, indicating ampicillin
sensitivity was not homogenous within the population. While only a few cells were
able to persist as these concentrations, few cells are needed to colonize a mouse gut.
Hektoen

LB

12.5

12.5

ii. coli 6925 (pBR322)

> 400

> 400

E. coli 6925 (pSAR)

> 400

> 400

~. coli 6925 (pSLAR)

> 400

> 400

6.25 - 25

6.25 - 25

E. coli 6925

S. Typhimurium 14028S

Table 1: Minimum inhibitory concentrations of ampicillin for all five bacteria
strains used expressed as Ilg/mL. A range is presented for S. Typhimurium. At 6.25
Ilg/mL the majority of the drop of bacterial suspension showed no signs of growth
but a few colonies could be seen growing within the ring. This was true up to 25
Ilg/ m L.
3.3 S. Typhimurium is ampicillin sensitive at low levels whell.gfown in culture
When given a single lethal dosage of ampicillin in culture, S. Typhimurium
demonstrates the same sensitivity as a known ampicillin sensitive strain of E. coli.
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Despite the detectable presence of both E. coli 6925 and S. Typhimurium upon
inoculation, within 12 hours, the presence of ampicillin had rendered both
undetectable by either spectophometric measures or plating (Figure Sa and Sb).
Conversely, E. coli 6925 (pBR322) detectable at a comparable level at inoculation
grew to mid-logarithmic phase within 12 hours (Figure Sc).
When grown in culture, S. Typhimurium does not demonstrate the ability to
survive in the presence of lethal dosages of ampicillin and demonstrates sensitivity
similar to that of a non-plasmid bearing strain of E. coli 6925. Unlike observations in
the host system, a single dosage was sufficient to eliminate a population of S.
Typhimurium while prolonged dosing with ampicillin could not eliminate the
bacteria from the mouse.
3.4 Attempts to clear S. Typhimurium from mouse gut were unsuccessful
The S. Typhimurium model was attempted in DBA/2J mice. However, many
of the mice died from infection within a few days despite treatment with ampicillin.
More notably, the last surviving mouse from this group was one from the cohort
receiving the lowest level of treatment. The most important information gathered
from this group was the inability to predict the course of infection in this strain of
mouse known to be more susceptible to S. Typhimurium than the 129xljsvJ strain of
mice. There is the possibility that some mice were injured during gavage. However,
there is greater possibility that these mice developed systemic infections that
ampicillin was not capable of effectively treating. Because these animals quickly
succumb to systemic infections, they are not a good organism in which to model the
progress of S. Typhimurium infection.
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Figure 5: CFUs of a) E. coli 6925, b) S. Typhimurium, and c) E. coli 6925 (pBR322)
over the course of 36 hours following inoculation into LB broth containing lethal
dosages of ampicillin. For c), the CFUs at 0 hours following inoculation was
approximately 3x10 4 , similar to the other two strains.
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In the more resistant mice, the model was more successful. Five cohorts of
two 129xljsvJ mice each were inoculated with S. Typhimurium 14028S and then
administered different dosages of ampicillin by bolus or drinking water: 200
Ilg/mL, 400 Ilg/mL, 600 Ilg/mL, a single bolus of 100 ilL of 500 Ilg/mL ampicillin,
and a single bolus of 500 Ilg/mL ampicillin followed by 200 Ilg/mL ampicillin in
drinking water. Ampicillin was administered for 12 days.
Cohort 4 received a single bolus of 100 ilL of 500 Ilg/mL ampicillin by gavage.
Prior to treatment, the detected bacterial load was 18.2 CFUs per milligram fecal
sample. 24 hours after dosage, the bacterial load increased and continue to remain
high, reaching a maximum of 2.38x10s during measuring (Figure 6). It appears that
whether by the nature of the infection or the nature of detection, the bacterial load
measured in fecal samples does not remain constant but can fluctuate quite
dramatically. While it began fairly low, it had increased by a factor of 1000 within a
few days and dropped back down to toward the end of measurement. This may be a
product of the animal becoming sicker as the bacterial load increased, eating and
drinking less, and therefore defecating less so that the fecal sample is not
representative of the current state of the colon environment.
Cohort 1 received a constant dosage of 200 Ilg/mL ampicillin in drinking
water. When treatment began, the measured bacterial load was 2.6Sx104 CFUs per
milligram fecal sample. After 24 hours of ampicillin treatment, S. Typhimurium CFUs
remained high, 2.76x103 CFUs per milligram fecal sample. After 48 hours, bacterial
load had decreased and remained low through the remainder of treatment. Samples
would be clear of S. Typhimurium for a few days and then would return a very low
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Figure 6: CFUs of S. Typhimurium from samples in Cohort 4 following bolus
administration.
levels without the readministration ofthe bacteria (Figure 7a). After 12 days of
ampicillin treatment, treatment was removed. Within 24 hours detectable bacterial
load returned to the same level observed before treatment, 3.28x103 CFUs per
milligram fecal sample (Figure 7b).
Cohort 2 received a dosage of 400

~g/mL

ampicillin in drinking water. When

treatment began, the measured bacterial load was 8.87x10 2 CFUs per milligram
fecal sample. After 24 hours of ampicillin treatment, the bacterial load remained
high. After 48 hours of treatment, CFUs in fecal samples decreased dramatically,
remaining undetectable for the last 5 days of treatment (Figure 8a). However when
ampicillin treatment was removed, within 24 hours, the detectable CFU level in fecal
samples became even higher than it had been prior to treatment, 9.07x103 (Figure
8b). Unlike Cohort 1, this high level of bacterial infection was not sustained,
although S. Typhimurium remained detectable for 4 days after removal of ampicillin.
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Cohort 3 received a dosage of 600 Ilg/mL ampicillin in drinking water. When
treatment began, the measurable bacterial load was 38.4 CFUs per milligram fecal
sample, much lower than the established bacterial load in the first two cohorts.
After 24 hours of treatment, as with the previous two cohorts, the bacterial load
remained close to the pretreatment level. After 48 hours of treatment with
ampicillin, the bacterial load dropped to undetectable; however, there were two
spikes when CFUs of S. Typhimurium were identifiable within the 12 days of
ampicillin treatment (Figure 9a). After the removal of ampicillin, the bacterial load
returned, at an even higher level than prior to treatment, 2.53xl0 3 CFUs per
milligram fecal sample (Figure 9b). Unlike the first two cohorts, bacterial level
return did not happen within the first 24 hours but instead took 3 days.
Cohort 5 received the single bolus of 100 ilL of 500 Ilg/mL ampicillin
followed by 200 Ilg/mL ampicillin administered in drinking water. Prior to
treatment, the bacterial load was detected at 2.61Exl03 CFUs per milligram fecal
sample. 24 hours after the administration of the bolus, the bacterial level had
decreased but returned to pretreatment levels 72 hours following the bolus
administration despite administration of ampicillin (Figure lOa). Unlike Cohort 1,
which also received 200 Ilg/mL ampicillin in drinking water, the detectable level of
S. Typhimurium remained higher in Cohort 5 throughout the course of ampicillin

treatment. Potentially, the original bolus of ampicillin had killed the extremely
sensitive S. Typhimurium cells, leaving the more resistant ones to persist. After the
removal of ampicillin, bacterial load increased to a level much higher than
pretreatment level, 2.51xl0 4 CFUs per milligram fecal sample (Figure lOb).
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Figure 10: CFUs of S. Typhimurium from samples in Cohort 5 a) during ampicillin
treatment and b) following removal of ampicillin treatment.
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4.

Dis.~ussion

Despite the sensitivity that S. Typhimurium demonstrated in vitro, based on
the return of the infection to detectable levels once the ampicillin treatment was
removed, the infection was not completely cleared in the murine model. While
there was no additional inoculation provided to the mice, it is not impossible that
they were contaminated in other ways. While mice with infections were separated
from those receiving treatment and their fecal samples processed separately, a
possibility is that animal technicans coming into the mouse room unknowingly
cross-contaminated cohorts. However, it may be more likely that the bioavailability
of ampicillin is so low that even at higher doses, it was not an effectively lethal
dosage to S. Typhimurium at physiological conditions.
It is also unclear whether a measurement of bacterial load through fecal samples is
an accurate impression of the internal state of the mouse infection. Even in
resistant strains of mice, S. Typhimurium may be able to grow within the epithelial
cells of the intestine [15]. While they may not be able to establish a systemic
infection from this point, due to the genotype of the host as related to Nrampl + vs.
Nrampl- and the resistance of their macrophages to harboring S. Typhimurium and

carrying them to other organs, the bacteria may impervious to ampicillin treatment.
Ampicillin has difficulty surviving the pH of the stomach and similar difficulty
crossing into host tissue, where it must travel to reach its target.
Moreover, if S. Typhimurium are moving inside epithelial cells, the bacteria
may not be detectable in fecal shedding, which was the measure of data collection
for this study. Removing the ampicillin may create a different environment that

39

either allows for more pathogenic bacteria to grow actively or allows the
recolonization of the gut within the luminal space by bacteria that have been hiding
from antibiotic treatment.
Because E. coli 6925 is very sensitive to ampicillin in vitro and is easily
cleared in the murine model, it is likely that the protective effect observed of
resistant E. coli for sensitive E. coli in the presence of ampicillin was supportive of
previous observations made in vitro, not the product of a nonlethal dose being
administered. E. coli 6925 (pBR322) provided no detectable protection for sensitive
E. coli while E. coli 6925 (pSAR) provided almost complete protection for sensitive E.
coli. E. coli 6925 (pSLAR) protected sensitive E. coli at an intermediate rate.
In vivo, by the methods used in these studies, it was not possible to

demonstrate the complete clearance of S. Typhimurium infection, even with high
dosages of ampicillin treatment. As such, it is uncertain that the protective effects
observed were actually protection but are more likely the product of a nonlethal
dose of ampicillin being administered.
Within the S. Typhimurium population, each bacterial cell may be more or
less susceptible to the mechanism by which ampicillin works. This was particularly
obvious in Cohort 5, which received a large single dosage of ampicillin followed by a
continuously available dose at a lower concentration of ampicillin. During the
continued ampicillin treatment, S. Typhimurium was able to persist at higher levels
than in the other three cohorts receiving continuous ampicillin treatment,
potentially this was due to the high one time dose, where a larger proportion of cells
within the S. Typhimurium population had lower levels of susceptibility.
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While the infection was never cleared, it was demonstrated that increasing
the ampicillin dosage was more effective at reducing the S. Typhimurium numbers.
In the case of Cohort 3 receiving the highest dosage of ampicillin within this study, S.
Typhimurium was not able to recolonize as quickly, either due to the longer time
needed for the mouse to metabolize ampicillin out of its system but more likely
fewer living cells were left to recolonize.
In vitro work with ampicillin also demonstrated that over time at room

temperature and at physiological temperature and pH the bactericidal properties of
ampicillin were reduced, indicating a degradation of the

~-lactam

antibiotic over

time under these conditions. Potentially in murine experiments, the dosage of
ampicillin did not remain at a constant level, and at lower effective ampicillin levels,
the S. Typhimurium cells were able to persist in the gut.
Because ampicillin was administered in drinking water, it was not possible to
control the intake of each individual mouse. Even if most S. Typhimurium cells can
be eliminated at low ampicillin doses in vitro, no measures were taken to determine
the serum level of ampicillin in the mice during treatment. Because there was a
delay of 48 hours in all cases before a dramatic decrease in bacterial load was
observed, it is likely that the mice have to build a certain level of ampicillin before
treatment becomes effective. However, the level of dosage appears to have been too
low to allow the mice to build a sufficient level to eliminate S. Typhimurium
infection. If an effective dosage of ampicillin is 60 mg/kg for mice (Anton 1982),
each mouse would have to consume 16.4 mL of water per day of 200

~g/mL,

which

is much higher than the mice consumed. Moreover, mice do not constantly drink.
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Potentially during periods of sleep or inactivity, the decrease in their levels of
ampicillin was sufficient to allow S. Typhimurium to persist. Patterns of eating and
the movement of food through the gastrointestinal tract may change the
bioavailability and therefore bactericidal properties of ampicillin. While
subcutaneous administrations of ampicillin have been the norm in previous studies,
oral administration may more quickly reach the site of infection but cannot be
controlled if administered in drinking water and may not produce an effective
dosage.
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CONCLUSIONS FROM IN VIVO MODELING
The purpose of the current research was to develop a protocol to model in
mice phenomena that had been observed in an in vitro setting. The nature of the
interaction between S. Typhimurium and its host proved to heavily influence the
ability to model within the mouse. S. Typhimurium behaves predictably in vitro.
The bacteria demonstrates sensitivity to ampicillin at low levels. However, within a
live host, the bacteria demonstrate an ability to evade both the attempts of the
immune system to eliminate it and the antibiotics delivered to the host. Much of this
survival may be mediated by the evolutionary history between host and pathogen.
The protocol that was used to administer the bacteria to the mice may also
have provided a better model for human gastroenteritis but it may have
inadvertently created a selective advantage for S. Typhimurium. Resistant strains of
mice like 129xlfsvj typically do not develop inflammation within the intestinal tract
in response to S. Typhimurium infection as is seen in humans [14]. Pretreatment
with streptomycin, as used in the current protocol, induces inflammation in the
intestinal tract that mimics that seen in humans [14]. However, this inflammation
allows S. Typhimurium to have selective advantage over the other bacteria that may
be growing in the gut, induding any more that may be introduced purposefully. For
example, in the inflamed gut, S. Typhimurium is able to use alternate carbon sources
that other microbiota are not able to utilize [15].
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Moreover, there is evidence that S. Typhimurium can grow within epithelial
cells of the small intestine, even in resistant strains of mice that do not develop
systemic infections [16]. This subpopulation of the infecting bacteria are found
within epithelial cells, in a state of hyperreplication, ready to re-enter the intestinal
tract from inside the epithelial cells [16]. Even in the instance of antibiotic
treatment, these bacterial subpopulations may be able to survive inside the
epithelial cells given the low bioavailability of ampicillin and its difficulty getting
inside host cells as well as bacterial cells. Upon removal of the ampicillin, these
bacteria may leave the epithelial cells, return to the intestinal lumen, and may be
able to recolonize the host. Despite the fact that based on fecal samples, the
infection had apparently cleared, upon removal of the antibiotics these bacteria
were able to recolonize the gut, which is why the return of infection was observed.
Clearly, some of these bacteria will be released from epithelial cells while treatment
with antibiotics is occurring. However, because so few are needed to colonize the
gut, if only a handful survive inside epithelial cells during antibiotic treatment, the
return of infection will be observed. The same return to recolonize is not observed
in an in vitro setting because there are no epithelial cells in which to evade
ampicillin activity. S. Typhimurium as a pathogenic bacterium, has evolved inside of
and along with its host and as such developed means to persist. The fact that it is
able to survive inside epithelial cells even in those mice that do not develop
systemic infections speaks to the bacteria's ability to evade the immune system as
well as maintain infection by constantly inserting new pathogens into the intestinal
tract.
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In order to develop a murine model for the protection of ampicillin-sensitive
S. Typhimurium by ampicillin-resistant strains of E. coli, the adaptive measures that

S. Typhimurium takes to avoid the host immune system must also be considered in
attempting to treat the infection with oral antibiotics. Dosage of ampicillin is one
consideration to the approach taken. Because the bioavailability of ampicillin is low,
even at dosages that eliminate the bacteria in the lab, S. Typhimurium is able to
survive inside the mouse, potentially because the effective dosage that the mouse is
receiving is significantly less than the concentration in the drinking water.
However, this would have to be carefully watched, because at some point high
dosages of ampicillin may be toxic to the mouse or, be too high for protection to be
afforded by the resistant E. coli.
Instead of streptomycin, another antibiotic may need to be used initially to
clear the gut of innate microbiota. Because streptomycin induces inflammation that
allows S. Typhimurium a selective advantage not normally found in the murine
model of S. Typhimurium infection, a different antibiotic may provide a more even
playing field for the two strains of bacteria introduced. Unfortunately, eliminating
the inflammation also eliminates the similarity with the human gastroenteritis but it
may allow more dissection of the interaction between a resistant strain of E. coli and
S. Typhimurium during treatment with ampicillin.
Ultimately, because many of the properties of S. Typhimurium are only
observed within a live host, they cannot be replicated in vitro. As such, it may never
be possible to develop a protocol for this model inside a host because S.
Typhimurium is able to persist with and without the presence of the resistant strain.
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CHAPTER 4
THE BEST OF TIMES AND THE WORST OF TIMES
How Salmonella uses Alternate Sigma Factors to Survive

1. Introduction
Salmonella enterica are rod-shaped, facultative anaerobic, Gram-negative

members of the Enterobacteriacae family [17] . Most people have heard of the
bacteria and generally associate it with food-borne illness. Despite general public
knowledge of the health risks associated and precautions taken to prevent spread,
Salmonella continues to cause many problems internationally. One approach

toward curbing this spread and reducing the negative impact of S. enterica could be
genetic analysis, with an ultimate goal of understanding why the bacteria are able to
survive host immune responses capable of eliminating most bacteria.
It has been suggested that the Salmonella genus diverged from Escherichia
coli somewhere between 100 and 150 million years ago [17]. While there is

evoluntionary distance between the two genera, much of the genetic information
has been conserved, and as a result, the study of one organism has provided insight
into the study of the other. Salmonella spp. are generally considered to be
pathogenic and can have both warm- and cold-blooded hosts [17]. More recent
evolution has occurred within the Salmonella genus itself. Salmonella enterica has
evolved into many different subspecies and serovars who manifest is dramatically

46

different ways across a variety of hosts despite sharing 95% of the same genetic
information [18]. From a medical and sanitation viewpoint, the genetics of
Salmonella are particularly important to study. Although a single-celled organism,

due to its long evolutionary history with humans and other host organisms, these
bacteria have developed several sophisticated mechanisms to survive immune
systems of its hosts, and evade sanitation efforts to kill it. Understanding this
survival at the most fundamental of levels may help to more specifically combat the
bacteria.
Salmonella typically reach their hosts through the consumption of

contaminated food or water. Once inside its host, the bacteria must persist through
various levels of pH, temperature, osmolarity, and nutrient availability [19]. The
pathogen must also face various attempts by the host's immune system to eliminate
it. The organism must address each different environment and assault on the
bacteria's integrity in order to survive. The ability of the organism to thrive in a
multitude of different environments and establish infection is mediated by the
regulated expression of different genes.
Because Salmonella is an important pathogen and can cause debilitating
disease and even death, research typically focuses is on the properties of the
organism that give it the ability to infect hosts. When studying virulence with
respect to genetics, there are a multitude of approaches. Once a gene of interest has
been discovered, the gene or gene product can be rendered nonfunctional and the
resulting phenotype examined. Conversely, given a particular phenotype,
researchers can examine genes present among strains sharing that characteristic.
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While there are a multitude of regulatory pathways within Salmonella that
can influence gene expression, one of the most fundamental comes from the usage of
alternate sigma factors by the cell's RNA polymerase. Sigma factors facilitate
differential gene expression by reversibly binding to the RNA polymerase core
enzyme and providing specificity for certain promoter regions. The various sigma
factors have different affinities for particular promoters as well as for the core
enzyme itself. Similar to other cellular proteins, sigma factors are regulated at a
variety of levels. Transcription in Salmonella, as in all prokaryotes, requires a sigma
factor, and ultimately all gene expression is affected by sigma factors activity.
Sigma factors were originally discovered as protein factors that stimulate
RNA synthesis from DNA using DNA-dependent RNA polymerase [20]. It was later
discovered that there were multiple sigma factors and that these alternate sigma
factors allowed for differential gene expression through different affinity for the
RNA polymerase core enzyme and for recognition of different promoter consensus
sequences. It appears that the majority of sigma factors are evolutionarily related.
These proteins all share four regions of similarity indicative of a common function
[21]. For the group of closely related sigma factors, special regions within the
protein recognize specific areas of the DNA as promoters versus non-promoter
regions [22]. These DNA regions include conserved sequences centered around the 35 and -10 positions with respect to the transcription initiation site. By truncating
the sigma protein at various locations, researchers have been able to determined
that four conserved regions of the sigma factors were responsible for locating
different areas of the promoter region. For example, region 4 of the sigma factor is
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found to recognize the consensus sequence around -35, while regions 2 and 3
recognize the -10 consensus sequence [22]. Region 1 of the sigma factor, the amino
terminus of the protein, blocks regions 2, 3, and 4 from interacting with the DNA
[23]. Binding of the sigma factor to the core enzyme blocks region 1 and allows
interaction of the other three regions with the DNA [6]. In this way, the sigma factor
cannot interact with DNA without being bound by RNA polymerase. While it was
understood that a sigma factor was necessary to facilitate transcription, their power
to regulate gene expression was not fully understood.
2. Early Virulence-Related Genetic Studies

As with most pathogenic microorganisms, early genetic research focused on
the disease-causing properties of Salmonella. Preliminary studies involving
virulence properties of Samonella revealed that in the absence of a functional copy
of several genes, the bacteria was unable to survive to cause infection inside its host.
Further studies of each of these genes revealed that while all of the genes were
required for optimal virulence, the gene expression was not under the same
regulatory control. Baumler and his colleagues examined nearly 30 mutant strains
of Salmonella Typhimurium that had shown attenuated ability to infect and survive
inside mouse macro phages [24]. These strains had been created by the insertion of
transposons in various locations of the genome and examining phenotype. By
sequencing the areas around the transposable elements, researchers were able to
identify that six of the regions disrupted by transposons corresponded to known
genes. Baumler concluded that these genes all made contributions to the virulence
properties of Salmonella.
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Some of the particular genes that Baumler concluded were disrupted in the
attenuated strains were purD, prc,j1iD, and nagA [24]. Other researchers have
examined the transcriptional control of these genes to understand why they are so
essential to the virulence capabilities of Salmonella. The dependence of these genes
on different sigma factors for expression shed more light into not only the ability of

Salmonella to survive in a variety of harsh conditions but also the virulence
mechanism of the bacteria.
As many sigma factors are closely related, there is a high degree of homology
between their structures and therefore promoter affinities. However, as few as one
or two base pair change can dramatically change which sigma factor recognizes the
promoter [25]. The purD gene encodes 5' -phosphoribosylglycinamide synthetase,
which is involved in purine nucleotide synthesis [26]. While these genes have easily
identifiable -10 consensus sequences, none appear to have the -35 region similar to
those typically recognized by primary sigma factor,

(J70

[27]. Further research

revealed this gene and others related to purine synthesis were all proceeded by
what researchers have called a Pur Box that seems to be required for their
transcription, as well as an area for regulation by purine levels in the cell [28]. These
PurBoxes are bound by repressor proteins that must be removed in order for
transcription of the pur genes to happen [28]. It stands to reason that purines
would need to be synthesized regardless of environmental condition. If
environmental conditions dictate the most dominant sigma factor and purines are
an essential part of cellular function in all conditions, multiple sigma factors should
be able to direct the transcription of their corresponding genes. Potentially, the
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ambiguity of the promoter region for these genes demonstrates the ability to be
used by multiple sigma factors and PurBoxes allow for regulation in a concentration
dependent manner.
A second gene, prc, encodes for a protease that in closely related organisms
has been found to playa role in response to cell wall stress [29]. In these organisms,
prc is preceded by a consensus sequence for a sigma factor showing a great deal of

similarity to the sigma factor in E. coli and Salmonella that responds to a variety of
global stresses, including damage to the cellular envelop [29].
The fliD gene encodes for part of the flagellar filament, needed for the
motility of the bacteria [21], [30]. This gene is proceeded by a consensus sequence
that can only be used by the flagella-specific sigma factor [21] and is part of a highly
temporally and spatially regulated pathway that ensures flagella are expressed
readily in times that motility is necessary and repressed when the bacteria has not
formed the appropriate primary structures for the flagellar.
The nagA gene product is N-acetylglucosamine-6- phosphate deacetylase in
E. coli and has the same function in Salmonella Typhimurium [22]. These gene was

found to have consensus sequence in the -10 region requiring the activating a
magnesium sensitive regulator in the presence ofthe housekeeping sigma (}"70 [31].
Based only on the extracellular availability of magnesium, the primary sigma factor
is responsible for the transcri ption of the gene provided a secondary regulatory
system is activated.
With the genes that Baumler examined, in combination with other research
indicating that each of these types of genes was under different regulatory control
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by particular sigma factors, a pattern began to emerge. Genes responsible for the
organism's response to particular threats to its integrity were under the
transcriptional direction by particular sigma factors. The importance of sigma
factors as transcriptional regulators is further revealed by their stability over time
[32] and the high degree of homology among sigma factors responding to a
particular stimuli between closely related species [33]. The use of alternate sigma
factors by Salmonella like all prokaryotes allows for a coordinated expression of
genes and an easily controlled process to promote survival even in the most harsh of
conditions.

3. A Tale of Six Sigmas ...
Individually, each type of sigma factor was purified, isolated, and determined
to facilitate RNA transcription in the presence of RNA polymerase core enzyme and
other appropriate molecules. To date, six different sigma factors have been
discovered within the Salmonella genome that are responsible for transcription
from a variety of promoters in response to different phases of the bacteria's lifestyle
as well environmental conditions. Acting together in a complex, as an
interconnected web of gene regulation, they enable Salmonella to withstand and
thrive inside infected hosts.
Sigma factors were characterized as proteins before their functions as
essential elements of the holoenzyme became clear. As such, each sigma factor is
known by a variety of names. Designations with rpo or Rpo are used across species
and refer to the particular stress to which a particular sigma factor responds. A
more contemporary convention is to use a lower case Greek sigma with the
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molecular weight of the sigma factor as s superscript. In this text, all molecular
weights refer to those found in Salmonella and E. coli.
Most sigma factors, a 70 , a E, a H , as, and a F, belong to the same family of sigma
factors, potentially all derived from some ancestral form or ancestral regulatory
process. The other sigma factor, aN, belongs to a different family, although it is the
only modern day example found, and may belong to a more ancient regulatory
system that has become obsolete with current lifestyles of bacteria like Salmonella.
While the housekeeping or primary sigma was found to facilitate most gene
expression during exponential growth, each of the other sigma factors was found to
help the organism address a number of different environmental stresses. Each
sigma factor has a consensus sequence in the promoter region for which it has the
greatest affinity. The relative affinities of mUltiple sigma factors for the same
promoter region may determine which sigma factor recognizes it at a specific
concentration of sigma factors within the cell. Much research related to sigma
factors has focused on determining sigma regulons, the specific suite of genes under
their transcriptional control.
3.1 aN - Nitrogen Regulation
aN, a 54 ,

or RpoN seems to be more evolutionarily distant from the other

alternate sigma factors than they are from each other, and it may be the remnants of
a more ancient regulatory system that has since become less important to survival
of Salmonella. In fact, some researchers believe that the processes governed by aN
may not be essential or may be under transcriptional control of another sigma factor
[34]. These processes include nitrogen fixation, dicarboxylic acid transport, and
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hydrogen oxidation [34]. Downregulating expression from RpoN-dependent genes
provides increases resistance to killing by host cationic antimicrobial peptides [35],
indicating that some of these processes may even be detrimental to the organism in
certain conditions. In some related species aN is related to pathogenicity, but that
does not appear to be in Salmonella [36].
The differences between aN and the rest of the sigma factors are profound.
There is almost no sequence similarity between the rpoN gene and genes for other
known sigma factors, also suggesting a different origin [34]. aN promoters are
unique in that they have conserved consensus sequences centered at -24 and -12
nucleotides from the transcription start site, as opposed to -35 and -10 conserved
regions found in promoters recognized by other sigma factors [37]. A highly
conserved RpoN-Box is involved in the recognition of the -24 and -12 DNA elements
[37]. The distance between the -24 and -12 elements is more stringent than the
analogous distance between the -35 and -10 elements for the a 70 family of sigma
factors, indicating a highly controlled regulation [37]. Moreover, the sequences at
the -24 and -12 elements have highly conserved GG and GC regions respectively,
also suggesting a high level of regulatory control [37].
While the aN protein is very different from other alternate sigma factors, the
interaction between the sigma factor and template DNA is also distinct. The a 70
family of sigma factors do not form stable closed complexes as part of the
holoenzyme and transcription will start spontaneously [37]. Unlike other sigma
factors, the aN and core enzyme form a stable closed complex. In this way, aN
binding to the core enzyme actually blocks transcription because the open complex
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must be activated [38]. The binding of the RNA polymerase holoenzyme with aN as
the sigma factor cannot induce DNA melting alone, similar to the RNA polymerase II
system in eukaryotes [39], which is essential for the start of transcription. In fact, it
has been hypothesized that aN may bind to DNA first rather than binding to the core
enzyme first [39]. This is supported by the fact that aN binds to a different location
on the core enzyme than a 70 and in doing so may be able to assist in DNA melting
once activated [39].
Because it forms a stable closed complex, the RNA polymerase with aN as the
sigma factor requires enhancer proteins for activation. Each enhancer protein is
under the regulation of its own signal transduction pathway, allowing response to
various environmental conditions [38]. All the enhancer proteins have in common
hidden ATPase activity that allows for the DNA melting necessary to initiate
transcription [38].
3.2 The Housekeeping Sigma a 70
The other five sigma factors appear to be evolutionary related, developing
from the original or primary sigma factor. RpoD or a 70 is the housekeeping sigma
factor and is responsible for the transcription of most of the genes in bacterial cells
growing exponentially [40]. When rpoD was found in the genome for E. coli, it was
determined that the gene sequence had a high degree of homology between other
rpoD genes from closely related species [41]. Further genomic analysis determined

that rpoD is found in an transcript with the 30S ribosomal protein S21 and DNA
primase [42]. This operon was the first discovered operon containing proteins
involved in transcription, translation, and replication [42]. Ea 70 (the holoenzyme
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containing the core enzyme associated with cr 70 ) does not form a stable closed
complex and transcription begins spontaneously [37]. Moreover, the cr 70
concentration found inside a cell undergoing exponential growth is less than
concentration of core enzymes, indicating the level of the sigma factor present may
regulate the level of transcription [42].
3.3

crE -

Response to Extracytoplasmic Stress

When the bacteria faces stressors, other sigma factors are involved in the
expression of genes necessary to survive the stress, such as

cr E , cr 24,

or RpoE, which

results in transcription of genes to combat envelop stress [43]. RpoE is
constitutively expressed in the bacteria, held inactive by interaction with various
binding proteins. The rpoE gene seems to be the most highly conserved of alternate
sigma factors across several species, as are the genes under its transcriptional
control, suggesting an high level of importance of these functions to the survival of
the mUltiple bacterial species.
RpoE must be able to respond to a signal coming from outside of the cell,
while the protein itself exists within the bacterium. It appears a transmembrane
protein, RseA, interacts with RseB on the periplasmic side and with crE on the
cytoplasmic side. An area of the DegS protein on the periplasmic side recognizes
unfolded proteins resulting in proteolysis of the periplasmic side of RseA. Cleaved
RseA is a target for RseP, which then cleaves the transmembrane portion of RseA,
releasing the RseA/ crE complex from the membrane and the unstable cytoplasmic
portion of RseA is quickly degraded by cytoplasmic proteases [44]. RseB also
interacts on the peri plasmic side with both DegS and RseP to control the activity of
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these proteases in the absence of a stress response [44]. Upon perception ofthe
extracytoplasmic stress in the form of misfolded proteins, (JE is then able to interact
with the core enzyme of RNA polymerase. The strength of the signal is directly
proportional to the number of misfolded outer membrane proteins, which is a
reflection of the extracytoplasmic stress.
While response to envelop stress is typically the signal necessary to release
RpoE from RseA, research has shown that acid stress may also result in the same. It
was found that mutants deficient in RpoE activity showed increased susceptibility to
acid and reduced ability to survive inside macrophages. The RseP domain was
required for this response to the acid shock, but its proteolytic activity was not
dependent on DegS [44]. It is proposed that the acidic milieu affects the interaction
between RseB and RseP, which normally keeps RseP inactive, so that RseP is
released to act on RseA to discontinue negative control over (JE [44]. Both DegS and
RseP have cytoplasmic and periplasmic domains, and the acid response appears to
be independent of the envelop stress response. Again, the strength of the response
is dependent on how much RseB is removed from RseP which in turn depends on
strength and length of exposure.
Once (JE is released to interact with RNA polymerase, not all

(JE -

dependent

genes are transcribed equally. Within the set of genes transcribed by RpoE, there
are different promoters with varying levels of affinity for the sigma factor. Within
the approximately 60 promoters examined that required

(JE

for transcription, there

were few very strong promoters (showing high affinity) but many relatively weak
promoters. The strong promoters were conserved across both E. coli and S. enterica,
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and were typically involved in maintaining porin homeostasis [45]. Varying
strength of promoters allow quick and efficient adaptation to different
environments by being able to transcribe different genes in response to various
signal [45]. If the stress signal is strong, the cellular concentration of cr Ewill increase
enough to transcribe at high rates from weak promoters.
In order to prevent wasted energy and further damage to the cell, the
activation of cr Ealso results in the downregulation of amp (outer membrane protein)
mRNA [46]. In this way the cell also prevents these nascent mRNAs from also
producing misfolded proteins while avoiding destruction by the exocytoplasmic
stress. Two small non-coding RNAs, Ryb8 and MicA, not under the control of RpoE,
collectively expedite the destruction of omp mRNAs. Under normal conditions, the
cellular machinery making outer membrane proteins is still not perfect and some
misfolded proteins are generated. In this case, the same two sRNAs are involved in
the response to clear the problem by inducing the cr Eresponse, but at a much lower
level that would be found in a bacteria responding to prolonged stress [46]. As such,
the two sRNAs are most likely under the transcriptional control of the primary
sigma factor and their increased activity helps to induce cr E-mediated responses.
As far as specific genes governed by crE, the parts of the cr Eregulon that are
highly conserved across species are involved in making the cell wall and outer
membrane of Gram negative bacteria [47]. The variable portion may be involved in
the alternative lifestyles that the studied species utilize. A genome wide search was
done for crE-dependent genes in several species including E. coli and S.
Typhimurium, determining that several genes were at the core of the cr Eregulon.
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Some genes were involved in making lipoproteins, such asy/iO,yeaY, andyraP.
Others were involved in outer membrane protein synthesis and modification, like
year, skp,jkpA, and degP. And still others were involved in cell envelope structure,

such as plsB, bacA, ahpF, andygiM. Interestingly, both rpoE and rpoH were both
under regulatory control of erE, indicating that erE promotes its own transcription
and the transcription of other sigma factors [47]. By autoregulation, erE can create a
multi-fold increase in gene product from its regulon as the extracytoplasmic stress
sigma factor. All of the genes found to be under the control of erE are related to
making proteins for cellular structure.
3.4 er H- Response to Heat Shock
One of the genes under the transcriptional control of RpoE is another sigma
factor, RpoH or er 32 [47]. This sigma factor has been found to be involved in the
transcription of genes that help Salmonella withstand high temperatures, potentially
as a result of fever response within the host. Whereas erE appears to mediate the
response to misfolded outer membrane proteins, er H seems to be involved with
proteins within the cytoplasm that are not correct [48]. Concomitant with increased
heat exposure, cell wall and membrane proteins begin to misfold and denature. As
the concentration of erE increases in response to the proteins that are misfolded in
the outer membrane, er Halso accumulates to respond to a sustained stressor. This is
supported by the finding that rpoH expression is directly proportional to erE activity
at temperatures higher than 42°C [49], a temperature at which protein denaturing
will reach inside the cell.
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RpoH governs the transcription of genes incudling those encoding proteases
that allow for the removal and recycling of misfolding proteins within the cytoplasm
to prevent damage to the cell. For example, an operon composed of opdA andyhiQ
was found to be immediately proceeded by a consensus sequence for the RpoH
promoter [50]. While the function of these two proteins is has not been directly
studied in the heat shock response, OpdA is metalloprotease oligopeptidase A, a
protease that would be helpful in degrading misfolded proteins.
Some researchers have also hypothesized that cr H is related to RNA
thermometers, which are other regulatory means for activating and utilizing heat
shock genes. RNA thermometers are areas of 5'-untranslated region that fold and
complementary pair in such a way as to block the Shine-Dalgarno (SD) sequence of
downstream genes [51]. When heated to sufficient temperatures, these areas
unpair to allow the ribosome access to the SD sequence. A previously undescribed
RNA thermometer was found within the 5'-UTR of the agsA gene in Salmonella. This
gene is known to be involved in response to heat shock and has a promoter region
containing a consensus sequence for RpoH utilization [51]. Withjn the agsA mRNA
appear to be RNA thermometer sequences [51].
In E. coli, a closely related species to S. Typhimurium, the rpoH mRNA itself
contains RNA thermometers. It appears in this species, the cellular level of the
sigma factor is controlled by complementary base pairing in the mRNA. Unlike
other RNA thermometers, the SD sequence in this case is not blocked but the start
codon is inaccessible to the ribosome and two halves of the ribosome-binding site
complementary pair at low temperatures [51]. Because of the importance of heat
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shock in bacteria as a whole, a similar mechanism is most likely at play in
Salmonella.

While responding to heat shock is vitally important for survival of the
bacteria, perhaps a H most important function is to mediate a E regulation of as
through hfq gene expression. In E. coli, the promoter sequence found upstream of
the hfq gene was found to be a H -dependent. The same promoter was found in S.
Typhimurium [48]. When nutrients are scarce, a E appears to up regulate as through
the increase of a H [48].
The product of the hfq gene, HF -I, is important for translation of RpoS. This
small protein is heat stable and binds to RNA to facilitate translation [52] by
associating with the ribosome [53]. Several possible mechanisms for the manner in
which the protein encoded by hfq regulated as translation have been suggested,
including by preventing the interaction of some sort of antisense mRNA or by being
directly involved in the transcription of rpoS [54]. Most evidence supports the
assertion that the function of HF -I is as a RNA chaperone after it was demonstrate to
bring the mRNA and ribosome in correct association for translation [55].
3.5 as - Stationary Phase Growth, Response to Stress and Starvation
The role of this sigma factor, also called a 38 , is slightly more difficult to define
than that of RpoE or RpoH. However, it is clear that the function of RpoS is essential.
The conserved sequence of rpoS across multiple species and within the same species
found in different geographical areas speaks to its importance. When rpoS genes are
characterized in clinical isolates, the mutations found are not clonal but rather
novel, implying that there is some selection against mutants. Even when strains
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demonstrated different abilities to survive certain stresses like exposure to
hydrogen peroxide, it did not appear to be related to different rpoS genes [56].
The number and types of genes that seem to be under transcriptional control
of as have a variety of functions and respond to a wide variety of lifestyle
requirements and threats to survival. The only known constant about the genes
transcriptionally governed by RpoS is their dependence on growth phase [57].
Previously, work has determined that during logarithmic growth, any activity from
as promoters is repressed by cyclic-AMP receptor activity [58]. Stationary phase

growth is characterized by a lack of cellular multiplication and decreasing cell
density. The transition from exponential growth to stationary phase growth is the
result of the concentration of a regulatory protein [59]. The concentration of Fis
(factor for inversion stimulation) a DNA binding protein, is high during exponential
growth and low in stationary phase. Fis binds to a region of DNA upstream of the
rpoS promoter and with decreasing amount, allows a switch to stationary phase

[59].
A genome-wide search has been done for genes under the transcriptional
control of RpoS. The project found that like RpoE, the as regulon includes promoters
of various strengths. Despite the assumed similarities between the E. coli and S.
Typhimurium genome and therefore the as regulon, there were several genes within
the Salmonella genome that were not homologous with any genes of E. coli, which
may speak to different lifestyles. Several genes of unknown function were found
under the control of as as well as ogt, which encodes for the enzyme 0 6

-

methyl guanine DNA methyltransferase [58]. This enzyme is responsible for
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repairing DNA damaged by alkylation. These results supported previous findings
that bacteria lacking a functional rpoS gene also cannot withstand DNA damage by
alkylating agents [60].
as also seems to playa role in a wide variety of other functions that ensure
the survival of the bacteria, such as protection from acid shock and nutrient
depletion. Decreased pH unfolds the secondary structure stem and loops of the rpoS
mRNA, allowing availability for translation [61]. With increasing pH, RpoS was not
degraded by proteolytic activity typical of protein turnover, but rather held inactive
by complementary basepairing rendering the mRNA inaccessible to the ribosome
when the acid threat had subsided. Constitutive degradation of the sigma factor
coupled with the lack of more protein being translated resulted in the system reset
after the acid threat had passed [61]. This is in contrast to previous work which
concluded that the protein MviA was responsible for responding to the acid shock
by increasing as level by preventing its degradation. In this work, lacking a
functional mviA gene resulted in overproduction of as and as - dependent
transcriptional units and increased tolerance to acid [62]. These two studies
examined bacteria in different stages of growth, one in logarithmic and one in
stationary, and potentially two different regulatory pathways are at play dependent
on growth phase.
The RpoS sigma factor also seems to be involved in survival of the bacteria in
nutrient depleted conditions. as has been found to act as both a positive regulator
for stiA and stiC and a negative regulator for stiR. These three genes are part of the
multiple-nutrient starving inducing loci. as was required for phosphate, carbon, and

63

nitrogen starvation survival through induction of stiA and stiC.

(Js

also acted as a

negative regulator of stiR during starvation-induced stationary growth [63].
3.6 (JF - Flagellar Formation and Chemotaxis
Flagellar assembly was originally assumed to be under the control of (J70
because it seemed essential to survival. However, examining promoters of known
flagellar genes found no consensus sequences for

(J70

[64]. Instead, researchers

found promoter sequences in Salmonella known to be used by alternative sigma
factors in closely related species [64].

(JF,

more commonly called FHA or (J2B, has the

most specific function of all the alternate sigma factors. FHA is involved in the
transcription of genes related to the formation of flagella, specifically the formation
of the flagellar filament [40]. Operons of flagellar assembly are proceeded by one of
three classes of promoters, class 1,2, or 3 [65], [66], [67], which allow for a
temporal regulation of expression of gene products. From these operons, more than
50 flagellar genes are transcribed [21].
There is only one class 1 operon which encodes the flhD andflhC genes [66].
Class 1 is the master opeon, with FlhD and FlhC acting as a global regulator of
flagellar assembly [67]. FlhD and FlhC form a heterotetrameric complex that is a
positive transcriptional activator of class 2 promoters through (J70 by interacting
with the a subunit of the core enzyme [65], [68], [69]. Class 2 operons include genes
for the assembly of the hook and basal body complex (HBB), (JF, and FlgM [65]. The
basal body, including the motor, penetrates the cell membrane and includes the
hook element on the extracellular side ofthe cell [69]. The filament protrudes from
the hook into the extracellular matrix and turns to provide motility.
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The third class of flagellar operons requires FHA for transcription [49].
Proteins generated from these operons are for the flagellar filament, the generation
of motor force, and chemotaxis [67]. FlgM which is also transcribed from class 2
operons along with FliA acts as an anti-sigma factor, keeping FHA inactive until the
completion of the HBB. The C-terminal ofFliA has a binding site for FlgM [21]. By
binding to FHA, FlgM prevents RNA polymerase core enzyme from interacting with
FliA to transcribe class 3 flagellar operons [71]. The FlgM protein is able to assess
the functionality and completion ofthe HBB because the protein itself is an exported
substrate [72]. Decreasing cellular concentrations of FlgM release FliA to interact
with the RNA polymerase core enzyme and transcribe class 3 operons for
completion of the flagellar filament [72]. The relative concentration of FliA to FlgM
determines the number of flagella that a single cell will have [73]. Additionally, the
FlhD /FlhC complex may assist FliA in associated with the RNA polymerase [73].
FlhD is involved in assessing nutrient state [74], which may make it necessary to
more or less mobile. Flagellar formation happens at a specific time during the cell
cycle, particularly right before the cell divides when the cell is at its largest and the
intracellular concentration of FlgM before exportation is at its lowest [73].
The intracellular concentration of FliA and FlgM is governed by other
regulatory mechanisms as well. The genes from both of these proteins can be
transcribed from either class 2 or class 3 promoters [75]. In this way, FliA can
positively and negatively regulate its own intracellular concentration dependent
upon the concentration of FlgM within the cell [76]. Over production of flagella is a
waste of valuable resources [77]. Mutants lacking FlgM make too many flagella and
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overexpress from class 3 operons [77]. Multiple promoters for genes needed in the
same cellular process allow for response to environmental conditions as well as
temporal regulation to avoid excess expenditure of energy by the bacteria [65].

4. Changing Sigma Factor~
The presence of alternate sigma factors has been well studied, but how do
the alternate sigma factors displace the housekeeping sigma or each other to govern
gene transcription? Most of the answer points to concentration dependence; that is,
the concentration of a particular sigma factor changes in response to different
environmental conditions. For example, RpoE is expressed constitutively but held
inactive by various other proteins until an extracellular signal is received. This
signal activates a series of proteolytic activity that gradually increases the
intracellular concentration of RpoE. Once RpoE is released, it is free to interact with
the core enzyme. RpoE is positively auto regulated and as genes are transcribed
from RpoE promoters, the intracellular concentration increases exponentially so
that RpoE can outcompete other sigma factors for binding access to the core
enzyme. RpoE in turn allows for transcription of rpoH, which summarily mediates
rpoS expression, so that the intracellular level of all three alternative sigma factors is

increased. Fine tuning of these concentrations allows for precise control of gene
expression. If a finite amount of RNA polymerase is available, increasing the
presence of one sigma factor can repress expression of genes requiring a different
sigma factor [78].
Growth phase also appears to playa role in the intracellular concentration of
certain sigma factors. During exponential growth, intracellular concentrations of (J70
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remain relatively constant and as is basically absent [79]. During stationary phase
growth, the intracellular concentration of as increases to nearly 30% of a 70
concentration [79]. Moreover, the concentration of the core enzyme decreases
during stationary phase growth [79], meaning that a 30% increase in concentration
is more than a 30% increase in competitive advantage. RpoS activity is repressed by
uspA and uspB, which are both under the transcriptional control of a 70 [78]. During

exponential growth, as is highly unstable [79]. In stationary phase growth, as is
released and free to interact with RNA polymerase core enzyme. Researchers have
hypothesized that there may be a a 70 anti-sigma factor under transcriptional control
of as or that a change in the cytoplasm may favor as - mediated transcription [78],
allowing the intracellular concentration of as to increase and guarantee more
interactions with RNA polymerase core enzyme. Most genes expressed during
exponential growth are not expressed during stationary phase growth, so a 70
proteins need to be rendered inactive [79]. Interestingly, the intracellular levels of
as reach those of a 70 during osmotic shock [63], indicating that the concentration of
a sigma factor can be a gradual or dramatic depending on the gene expression
required to survive a particular situation.
Environmental conditions can also playa role in the stability of the proteins
which can affect transcriptional efficiency. For example, RpoH, the heat shock sigma
factor, is high unstable at low temperatures but above 42°C intracellular
concentrations will transiently increase [79]. Higher temperatures may provide
increased efficiency of a H - mediated transcription or they may stabilize the protein
itself so that it is able to interact with the core enzyme [79].
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With the idea of differential gene expression through alternate sigma factors
in mind, it is possible to see how Salmonella is able to respond quickly and
efficiently to a wide array of environmental conditions inside its host and elsewhere.
But the picture is not complete without an understanding of the lifestyle of
Salmonella to provide insight into the phenotype resulting from the differential gene
expression.

5. Salmonella as a Pathogenic Bacteria
In determining how alternate sigma factors are able to promote survival and
spread of Salmonella, it is important to understand how Salmonella infects its hosts
and how it avoids attempts by the host to eliminate its threat. Typically, genes are
discovered that are related in some way to the survival of the pathogen and then
later research is required to reveal how the transcription of the particular gene is
controlled. Research involving Salmonella has found that transcription control
through alternate sigma factors provides an elegant means of balancing gene
expression and energy usage with pathogenic requirements. By examining
phenotype and then determining the underlying genotype, researchers have been
able to determine how Salmonella is able to lead a pathogenic lifestyle.
Salmonella typically enters its host through the oral route. If sufficient
numbers are ingested, some organisms will survive the low pH conditions of the
stomach to reach the small intestine [17]. Sometimes the bacterial infection is
halted here. For a systemic infection to occur, the bacteria must invade the gut
epithelium [80]. Salmonella preferentially invade epithelial cells in the distal ileum
of the small intestine by adhering to and then injecting effector proteins into the
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host cell [81]. The small intestine provides an environment of near-neutral pH and
high osmolarity, condusive to bacterial invasion not found in the large intestine [82].
Within the small intestines, Salmonella specifically invades Peyer's patches
through M cells. Peyer's patches are specialized lymphoid tissues that are designed
to sample intestinal antigens and lead to immune responses [83]. Salmonella
exclusively enter M cells which are found within the follicle-associated epithelium of
Peyer's patches [84]. M cells are epithelial cells responsible for the uptake of
luminal antigens [83] and can engulf large particles, making them ideal for target by
Salmonella [68]. When one bacterium makes entry into the host epithelial cell, it
recruits other pathogens to its location [85].
Not all Salmonella infections spread from the gastrointestinal tract into the
rest of the host's body, causing a systemic infection. However, if the infection is to
become systemic, the bacteria must be able to spread and colonize beyond the small
intestine. The presence of the pathogen in M cells causes damage to the integrity of
the epithelial cells allowing for dissemination. Salmonella presence in the M cells
becomes cytotoxic within an hour of infection [84]. In this way, Salmonella is able to
disrupt barriers between cells to allow for migration [86]. The death of these M
cells causes gaps to form in the surrounding epithelial tissue, allowing the bacteria
to spread laterally along the basal lamina or deeper into the follicle [84]. From this
point, the bacteria can spread through the bloodstream and lymphatic system to
mesenteric lymph nodes and other deeper tissues [17]. Eventually through the web
of pathways in the vascular and lymphatic system, the bacteria is transported to
other organs in the body where it can lay dormant or undergo further replication
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[17]. It most commonly reaches the lymph nodes, liver, or spleen [87]. Induction of
inflammation around the initial site of infection results in the recruitment of more
immune cells and causes diarrhea which can allow the spread of the bacteria to
other hosts and other environments [82].
The travel of Salmonella through different cell types is governed by the
bacteria's ability to induce it's own internalization into non-phagocytic cells [88],
[83]. This process is contact mediated and begins when the bacteria touches
epithelial cells of the small intestine. Salmonella contact with host cells causes
changes in the host cells' plasma membrane [89]. The bacteria are able to induce
degradation of microvilli and the formation of cytoplasmic projections from the host
cell to surround and enclose the bacteria in membrane-bound vesicle [84]. The host
cells responses to the bacteria appear to be localized, limited to the areas of contact
between the bacteria and the host cell [88]. The complete internalization ofthe
bacteria seems to require the adherence of the bacteria cell to the host cell.
Salmonella has evolved a mechanism that uses components of the host cell's cellular
machinery to result in its internalization into the cell, specifically the epidermal
growth factor receptors [88].
This induced internalization by host cells is not limited to a specific cell type
but has been found to occur in all types of eukaryotic cells [89]. Because the
invasion mechanism is not cell specific, a candidate process would have to be
present in all eukaryotic cell types. Fimbrial genes are transcribed from several
operons, each with different fimbrial types [90]. Fimbrial proteins may guide the
bacteria to the epithelial cells based on certain molecules present on the surface of
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the eukaryotic cells and different fimbrial types may target bacterial cells to
different cell lines [90].
The ability to be internalized by non phagocytic cell is one distinct
characteristic of Salmonella. The other hallmark of a Salmonella infection is the
ability to survive and replicate inside phagocytic cells like dendritic cells and
macrophages [80], both of which are present in large quantities in the Peyer's
patches [91]. In fact these cell types seem to rapidly migrate to the area of invasion
as soon as the bacteria attaches to the epithelial cells [86], a phenomenon not
observed with commensal E. coli. Some researchers suspect that the bacteria
stimulates the host cell to release transcellular chemical signals that cause the mass
migration [86]. Because of the necessity these bacteria have to evade the immune
system by surviving in phagocytic cells, this mechanism may have evolved to allow
the bacteria to gain access to macrophages and dendrites before an immune system
response can be mounted.
While both dendritic cells and macrophages are important components of the
host immune system, the lifestyle of Salmonella inside each is different. While inside
macrophages the number of bacterial cells increases dramatically, there is no
change in the number of bacterial cells inside dendritic cells [92]. Logically, this
difference may be based on the different functions of dendritic cells and the
macrophages within the host immune system. In fact, the ability of Salmonella to
colonize a particular species may be mediated by the ability to survive within
dendritic cells of that host [93].
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6. The Immune System Response
At each step in colonization of different cell types, Salmonella are faced with
an onslaught of attempts by the host's immune system to eliminate the bacteria.
Host immune systems are able to mount two types of immune responses against
bacterial invasion: constitutive and inducible [94]. Constitutive defenses include
barriers like the mucosal epithelium. They are typically present only at the area of
exposure and the destruction is direct only at the invading pathogen [94]. Also
included in constitutive immune responses is gastric acidity, which has long been
considered as a way to prevent ingested microorganisms from migrating out into
the rest of the body [95]. Typically, the pathogen is ingested along with food or
water which is by comparison to the conditions inside the host body, lower
temperature, more neutral pH, and lower nutrient content [83]. As it travels
throughout the host, the pathogen faces reduced pH in the stomach then higher pH
in the small intestine and higher concentration of bile salts than in the stomach [83].
Other immune responses are induced upon infection. Major targets of the
innate immune system are pathogen-associated molecular patterns (PAMPs). The
recognition of these PAMPs result in uptake by dendritic and phagocytic cells [94].
Just as Salmonella has evolved a mechanism to get inside nonphagocytic cells, these
bacteria have also acquired the ability to survive inside phagocytic cells that help
the innate immune system eliminate them from the host body.
Dendritic cells transfer information about the bacterial pathogen to the
adaptive immune system by recognizing PAMPs and capturing and degrading
bacteria to be presented to T cells [81]. As such, inference with this mechanism
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promotes bacterial survival [81]. Bacteria bypass the typical processes within
dendritic cells to prevent presentation of antigens to T cells. Adaptive immunity to
Salmonella requires B cells and T cells primed by mature dendritic cells [96]. The

bacteria is enclosed inside a vacuole within the dendritic cell called a Salmonella
containing vacuole (SCV). Usually, the dendritic lysosomes fuse with vesicles
containing engulfed pathogens inside the cell, degrade the bacteria, and present
various pieces to T cells [81]. Inside the dendritic cells, Salmonella restricts
expression of genes that produce proteins recognized as PAMPs to the inside of the
cell, preventing dendritic cell maturation, and antigen presentation [96].

7. Islands of Pathogenicit}'

Virulence factors are properties of the pathogen that allow it to invade and
infect a host [83]. These include genes encoding products that would allow
Salmonella to enter epithelial cells and survive in macrophages and dendritic cells.

An estimated 5-10% of genes within the Salmonella genome can be considered
virulence genes [83]. Some of these genes have been found arranged in clusters
within the Salmonella chromosome, called Salmonella Pathogenicity Islands (SPIs).
It has been theorized that these gene clusters were acquired by horizontal transfer
due to the higher G-C content that in other parts of the Salmonella chromosome [83]
and similar regions are not found in closely related commensal species such as E.

coli [89]. There are at least five known SPIs, but SPI-1 and SPI-2 are known to playa
role in the initial phases of infection. Both SPI-1 and SPI-2 encode type III secretion
systems (TTSS), although they perform different functions [97]. Additionally, genes
within the SPIs encode both effector proteins and regulatory proteins [80]. These
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two secretion systems allow the insertion of effector proteins into both the
extracellular environment and the host cell.
In general, SPI-l appears to contain genes involved in bacterial uptake by the
host cell, while SPI-2 genes contribute to survival inside cells [98]. However, there
is some evidence that SPI -1 may also be important for life inside the vacuole for
intracellular replication [99]. Some gene products of SPI -1 physically link the TTSS
to eukaryotic cells by being injected into the plasma membrane, and recruiting other
host cell factors to allow internalization [100]. Secreted proteins from genes
transcribed from SPI -1 leads to actin cytoskeleton rearrangements of the host cell
that bring the bacteria into the cell in a membrane bound vesicle [101]. SPI-l genes
include those for effector proteins that trigger signal transduction pathways within
the host cell to promote the internalization of the bacterial cell. A variety of host
functions can be hijacked to serve the bacteria's purpose, including cytoskeleton
arrangement, vesicular trafficking, cell cycle progression, and programmed cell
death [98]. SPI-l effector proteins activate GTP-binding proteins such as Cdc42,
Rac-l, and Rho, which coordinate intracellular activities in the host cell [101]. Once
the bacteria has been brought inside the cell, the actin rearrangement must be
reversed to enclose them. This is done through other effector proteins that
down regulate actin rearrangement [102].
An important series of proteins called Salmonella invasion proteins (Sips) are
intimately involved in the ability of the bacteria to induce the host cell to internalize
it and are found in the SPI-l gene clusters. These proteins are translocases required
for the intimate association of bacteria with host cells [98]. SipD is found on the
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bacterial surface prior to contact with the host cell, and may act as a sensor of
appropriate host cells to invade [98]. SipA does not cause the membrane ruffles in
the epithelial cells associated with the internalization [103], but mutants with
deficient sipA genes create ruffles that are not preferentially located at the site of
bacterial contact [104]. Evidence is mounting that SipA mediates the actin
rearrangement that allows for the internalization bacteria [104]. SipB and SipC are
found on both host cell and bacteria after contact has been made [98]. SipC, works
independently of host cell function, by bundling actin filaments into cables to allow
for rearrangement favorable to the entry of bacteria [105]. SipC performs functions
similar to those found within eukaryotic cells, but show no primary similarity with
eurkaryotic proteins with similar function [105].
Another group of important Salmonella proteins are the invasion proteins.
When delivered orally, bacteria with missing or incomplete invasion regulons are
unable to colonize the small intestine or the spleen [106]. However, when delivery
is through a method other than oral, these strains are able to establish infections in
both of these organs, indicating that these gene products may be essential for the
establishment of infection after oral exposure to the bacteria [106].
Transcription of all SPI-l operons is activated by a regulatory loop beginning
with HilA [107]. Through other regulator proteins like HilC, HilD, and InvF,
expression of invasion genes is modulated by HilA [87]. Interestingly, a rising
concentration of acetate in the distal intestine can activate the expression of HilA by
bypassing normal positive regulators of expression [82]. The bacteria has evolved a
mechanism to increase expression of its invasion proteins when in the right place.
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While SPI -1 may playa role in the procession ofthe infection past the initial
invasion of epithelial cells, SPI-2 is vital for the migration of bacteria to other parts
of the host [108]. SPI-2 was the second pathogenicity island discovered and is
required for survival after bacteria has entered epithelial cells [97]. Mutants
without SPI-2 genes can enter Peyer's patches but were unable to spread to
mesenteric lymph nodes [109]. It also appears evolutionarily speaking that SPI-2
was acquired after SPI-l. The ability to spread and survive past the epithelial tissue
of the small intestines allowed the expansion of the ecological niche of Salmonella
[109]. Not all members of the SPI-2 pathogenicity island are equally vital for the
ability of the pathogen to establish systemic infection. Mutants with various genes
knocked out show a varying level of attenuation [109], [110]. However, the genes
within the SPI-2 are responsible for avoiding destruction by lysosomes within
dendritic cells and macrophages [111]. Expression of SPI-2 genes seems to be
induced by the slightly acidic conditions inside the initial vacuole formed when the
bacteria is internalized by the host cell [108].

8. Regulation of Salmonella Pathogenicity Islands by Sigma Factors
Regulatory control of SPls can be exerted by sigma factors. SPI -1 genes are
typically transcribed using Ecr70 . cr H mediates SPI-1 expression by regulating
activators of SPI-l. Systems mediated by RpoH negatively relate HilD
posttranslationally and HilA transcriptionally [108]. HilD is responsible for
activating HilA transcription, and HilA in turn activates all the genes within SPI-1.
cr H directs the production of Lon protease which specifically degrades HilD [108].
Through modulating the activating of cr H, the bacterial cell can control SPI-1
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expression. This ensures that SPI -1 expression can be restricted to specific regions
within the cell [108]. Moreover, as a H is usually used for transcription in the event
of some stress to the bacteria, the expression of genes from a H, such as Lon protease,
can restrict the expression of SPI -1 genes during stress. In this way, the cell can
repress invasion genes long enough to replicate, escape, and invade a new
macrophage before cell death [91].
Promoters for SPI-2 genes all have consensus sequences for a 70 [112].
However, upstream of some of the genes seemed to be consensus sequences for a E
that researchers assume may be functional but non-canonical a E binding sites [96].
Researchers postulate that these a E binding sites may serve a couple of different
purposes. The a E - recognized promoters may allow the bacteria to expression TTSS
in response to host factors that compromise the bacterial cellular integrity [112].
Alternatively, a E may fine-tune the expression of SPI-2 genes through a70 [112] by
preferentially overexpressing certain genes while all others are expressed at basal
levels by a 70 .
Stationary phase Salmonella are unable to cause the actin rearrangement in
host epithelial cells that is necessary for entry [85]. Invasion factors are either not
functional or not expressed in stationary phase bacteria [85]. As growth phase has
been demonstrated to change intracellular concentrations of different sigma factors
and virulence genes do not appear to be under the transcriptional control of as,it
stands to reason that these bacteria would not be able to invade as they are not able
to expression invasion genes because the activity of the necessary sigma factors is
repressed.
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9. Other Genetic Sources of Virulence
Virulence genes contained outside Salmonella Pathogenicity Islands
contribute to host colonization and are regulated by sigma factors. Once outside
the mammalian small intestine, invasion loci are not necessary for spread and
nutrients are usually limited. For example, the location of the Spv regulon varies
among Salmonella species from the chromosome to a plasmid, yet all species carry
the genetic locus, which contributes to intracellular growth once bacteria has spread
outside of the small intestine [33]. The dependence on the alternate sigma factors
for the expression of these genes is illustrated by the inability of as mutants to
efficiently express the Spv regulon. Expression of one of the members of the Spv
regulon, spvB, was decreased by 86% when as was knocked out [50]. In a functional
sense, the lethal dosage in mice for a strain without a functional rpoS gene was 1000
fold greater than wild type [50].
The dependence of Spv regulon expression on growth phase also indicates a
dependence on as for transcription. However, it seems to be nutrient availability,
not cell density, that is most important in mediated Spv regulon expression [33]. as
associated with RNA polymerase results in expression of genes that are essential to
help the bacteria survive nutrient depleted conditions, such as those found in
deeper tissues beyond the small intestine [33].

as increases expression of spv virulence genes by interacting with SpvR, a
repressor protein for the virulence plasmid [97]. Competition for RNA polymerase
between as and 0'70 led to less efficient transcription of spvR from its promoter as as
has a greater affinity for RNA polymerase than 0'70 but a lower affinity for the
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promoter for spvR [113]. as affinity for RNA polymerase is enhanced by its
interaction with Crl, giving it the ability to displace a70 as the preferred promoter
[114]. The presence of SpvR regulates its own transcription [113] so the lack of
efficient transcription leads to decreasing cellular levels which lead to the
derepression of spv plasmid virulence genes. as ensures that enough SpvR is present
to activate transcription from the spvA promoter, the first gene in the regulon [33].

10. A Sigma Factor Cascade Contributes to Survival in Phagocytic Cells
While Salmonella Pathogenicity Islands allow bacteria to invade host cells,
the pathogen must also survive the hostile environment within. While differential
gene expression through various sigma factors ensures the appropriate expression
of SPIs during access to the intracellular milieu, the use of sigma factors also permits
subsequent survival. Ferric Fang describes a cascade of transcription and
translational events that involve sigma factors associating with the core enzyme to
transcribe genes for each other and those necessary to respond to a variety of
assaults in the intracellular environment [115]. The first step in the cascade is
activation of aE'which is constitutively expressed through a 70 promoters but held
inactive by a pair of negative regulators, RseA and RseB [116]. RseA interacts with
a E in such a way to block the binding site for RNA polymerase [44]. When an
extracytoplasmic stress is perceived, a Eis released by RseA and freed to bind to RNA
polymerase. Interaction of a Ewith the core enzyme allows for transcription from
other promoters. These promoters include those before the a Eregulon of genes but
also before the rpoH gene, which encodes the alternative sigma factor, a H• a H
provides specificity for RNA polymerase to transcribe genes in the a H regulon, which
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respond to cytoplasmic stress. Additionally, a H allows transcription of hfq. The Hfq
protein interacts with the rpoS mRNA to facilitate its translation. The as then allows
transcription of genes under its transcriptional control, which allow for a starvation
response [115]. This overall cascade allows for coordinated response by the
pathogen. To ensure that sigma factors help transcribe genes needed to respond to
stress only as long as it exists, there must be some mechanism of turnover [115]. In
this way, the use of an interconnected web of sigma factors allows the Salmonella to
gain access to various cell types and then survive within the cells to be able to
spread to other areas of the host.
This cascade's vital importance to survival in particular within macrophages
is illustrated by the increased levels of as inside the macrophage following infection.
Some aspect of being inside a macrophage results in increased transcription of the
rpoS gene. While levels of the housekeeping sigma a 70 decreased, levels of as

increased about 10 fold a few hours after infection [117]. The conditions inside the
macrophage induce the stress response and restrict nutrient availability, which
induces the sigma cascade of gene expression to help the bacteria survive, not
necessary become virulent.
11. Sigma Factors Coordinate Gene Expression Together

Rarely is gene expression controlled in a strictly linear manner. That is,
multiple sigma factors may work together to fine tune expression of a group of
genes to provide the bacteria with the high probability of survival. The cascade of
sigma factors to be able to survive inside phagocytic cells described above is just
one example. There are many other instances of sigma factors working
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simultaneously to express a certain suite of genes to allow response to a particular
stimulus.
One way to determine if one sigma factor plays a role in the efficient
transcription by the other is to knock out one of them and see how the function of
gene products mediated by the other are effected. In this way, researchers
determined a relation between RpoE and FliA. Mutants without rpoE showed
defective or limited mobility [118]. In these mutants, expression from class 1
flagellar promoters remained unaffected while some class 2 and most class 3
promoters showed decreased activity as compared to wild type [118]. Researchers
concluded that RpoE may promote expression from class 3 promoters by mediating
expression of FliA during osmotic stress, such as the hyperosmotic conditions found
in the small intestine [118].
RpoH and RpoN also appear to be related in their ability to control the same
genes as well as the dependence of one on the other. Expression of some heat shock
operons appear to be under the control of RpoN in certain conditions, as expression
from a H operons is down regulated in mutants with rpoN knockout [36]. In this way,
RpoN may be responsible for fine tuning some gene expression during heat shock
response. The expression of topoisomerases also appears to be governed by both aN
and a H [36], which may also indicate an interdependence of the two sigma factors on
the activity of the other.
Insufficient expression of one sigma factor can be compensated for by
overexpression of other sigma factors. For example, inside macrophages while RpoS
only moderately increased following infection, RpoH and RpoE showed dramatic
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increases in intracellular concentration [119]. While RpoS is typically associated
with virulence inside phagocytic cells, it may be possible for other sigma factors to
express a suite of genes by working together to achieve the same end result.
Research has also demonstrated that RpoN can compensate for insufficient RpoS in
the formation of certain lipopolysaccharides [120]. RpoE is able to mediate RpoS
levels during stationary phase growth through RpoH and the RNA chaperone Hfq to
ensure appropriate gene expression to respond to diverse stressors [48].

12. Survival Outside of a Host
While Salmonella is an important enteric pathogen as it infects many hosts
and can be transmitted from species to species, it also is able to survive outside any
host. Because of this characteristic, it has been an important target of sanitation
processes to eliminate possible sources of transmission. Unfortunately for food
service personnel, Salmonella have also evolved a variety of strategies to withstand
attempts to eliminate them from food sources, some of which have been found to be
modulated by the use of alternate sigma factors. There are basically three strategies
to eliminate bacteria in food service: high temperatures, low temperatures, and
washing. Salmonella has evolved mechanisms to unfortunately survive many of the
attempts to eliminate it.
Because Salmonella can infect a variety of hos~s, one means of transmission
to human hosts is through food products that are infected themselves, such as
poultry. The same mechanisms of alternate sigma factor used to survive acid
challenges in a mammal gut are also utilized in surviving the fowl gastrointestinal
tract and can lead to transmission of the pathogen to a new host [121].
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Other studies specific to food handling procedures and alternate sigma
factors have determined that RpoS, for example, is essential to Salmonella's ability to
withstand normal sanitation procedures common in the food service industry and
that early induction of RpoS can cause the cells to enter stationary growth phase
prematurely, negating the protective nature of stationary growth to the pathogen's
ability to survive [122]. Other studies have demonstrated that certain food handling
processes, such as washing in various antimicrobial agents, can induce RpoS to
protect the bacteria from destruction [123]. Significant drops in temperature have
also been found to activate transcription from ers dependent promoters rather than
from the er 70 promoters from which genes are normally transcribed, indicating that
ers may help the organism survive in cold temperatures [124].
Sometimes multiple alternate sigma factors contribute to survival through
food processing. For example, erSand erE were both found to be important in
surviving refrigeration and changes in osmotic pressure. Depending on the nature
of the stress, either er s or erE may be more important and their relative concentration
dictated the type of response [125]. In short, Salmonella employs the same
strategies to survive food processing as it does to survive changing environmental
conditions inside its host.

13. Regulation of Sigma Factors
Because sigma factors are capable of dramatic changes in cellular protein
composition and energy use, their effects must be closely guarded to ensure that the
pathogen is responding to the stress without exhausting cellular resources. Some
alternate sigma factors are constitutively expressed but held inactive until they are
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needed by regulatory proteins that change conformation or leave the cell in
response to a particular signal. For example, RpoE is held inactive until an
extracellular signal of extracytoplasmic stress is received and FliA is held inactive by
FlgM until the FlgM is exported out of the cell by the completed hook and basal body
structure. Some regulation of sigma factors is accomplished by the optimal
conditions under which they can influence gene expression. For example, rpoH can
not be translated below a certain temperature because at lower temperatures the
mRNA folds back on itself blocking the start codon. And RpoS shows increased
efficiency at stationary phase growth and is almost nonexistent during exponential
growth, potentially due to a change in the intracellular milieu caused by a different
growth stage.
Because much of the efficiency of sigma factors to influence transcription is
influenced by their relative concentrations within the cells, many mechanisms to
regulate them change the available concentration of these proteins. Different
proteases target specific sigma factors and depending on the relative concentration
of these proteases, the relative availability of the sigma factors can be adjusted. As
the concentration of core enzyme is constant, this can dramatically effect gene
expression.
Because of the wide variety of genes under its transcriptional control and the
ability of RpoS to elicit a strong response, its activity must be closely monitored by
the bacteria. Several novel pathways of regulation have been discovered, and it is
almost certain that others exist. DksA is required for efficient translation of rpoS but
not at the same location as the protein product of hfq [126]. Another protein, RstA,
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decreases the expression of RpoS controlled genes and appears to decrease cellular
levels of RpoS independently of proteolytic activity [127]. Translation of the rpoS
mRNA is elevated in the presence of appropriate carbon sources, indicating a
growth rate dependent control of sigma factor availability [38]. In response to
increased glucose levels, StpA prevents overactivation of as indirectly enhancing its
turnover [128]. Some small mRNAs such as DsrA and RprA, are highly conserved as
are their antisense elements within the rpoS mRNA but only have small effects on
RpoS availability [129]. DsrA interaction with rpoS mRNA disrupts the stem and
loop base pairing of rpoS mRNA to allow high levels of translation [130]. The same
study discovered another small RNA, RprA, that interacts in a similar way to
positively regulate RpoS translation [130]. The high number of complex regulation
systems that operate independently of each other speak to the need to be able to
quickly change RpoS activity as well as to the functions that RpoS helps to mediate.

14. Sigma Factors and Other Regulatory Mechanisms
Differential gene expression through alternate sigma factors is far from the
only regulatory mechanism with Salmonella and there are points in the response to
environmental stimuli that these other regulatory pathways are influenced by or
influence alternate sigma factors. Two important regulators that intersect
differential gene expression with sigma factors are the PhoP /PhoQ regulatory
system and the Fis global regulator.
The PhoP /PhoQ regulatory system influences the expression of many genes
and is functionally a sensor of extracellular magnesium concentration. It has been
found to have evolved differently in closely related species like E. coli and
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Salmonella as a result of different lifestyles [131]. The relation between the

PhoP /PhoQ regulatory system and as appears to be essential. Even in cells with
functional copies of rpoS, mutants lacking PhoP cannot form functional phagosomes
within phagocytic cells [132]. Mutants with a double knockout ofthe RpoS and
PhoP /PhoQ show decreased virulence and decreased invasion of host cells [133]. It
has even been suggested that because of their inability to cause lasting infections,
these double knockouts should be used to make a Salmonella vaccine [133].
PhoP controls the level of available RpoS by controlling proteins which
enable its degradation by ClpXP. PhoP acts as a transcriptional activator for iraP,
which encodes for a protein that interacts with RssB. RssB facilitates ClpXP
degradation of as [134]. By blocking RssB activity, the level of as accumulates
during PhoP /PhoQ activation, which includes low levels of magnesium as found
inside macrophages. This is very different than the type of regulation seen in the
commensal E. coli [134], indicating that while there is some similarity in the genes
expressed between the two, the regulation of the alternative sigma pathways is not
the same.
Interestingly, RpoE seems to be involved in the regulation of PhoP /PhoQ
activity through Hfq, the same RNA chaperone through which it mediates RpoS
expression [135]. As RpoE is at the top of a cascade that leads to increased RpoS
concentration, it stands to reason that there would be a multitude of ways through
which RpoE regulates RpoS level.
Fis (factor for inversion stimulation) is a global transcription regulator and
facilitates site-specific DNA recombination [136]. The intracellular concentrations
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of Fis are high during exponential growth and low in late exponential and stationary
phase growth [137]. The fis promoter itself is of some interest into how these
concentration differences are maintained. It is a 70 dependent and growth-phase
dependent regulation from this promoter is achieved through a weak -35 sequence,
a second RNA polymerase binding site, and the relative concentration of nucleotides
within the cell [138]. The fis promoter is somewhat unique among a 70 - dependent
promoters in that transcription begins with a cysteine [137]. This residue is
normally a poor initiator of transcription and as a result the RNA polymerase
holoenzyme binds very weakly with the fis promoter [137]. When cellular
concentrations of cysteine are low, there is very little transcription from the
promoter but as CTPs increase in the cell, so does gene expression from the fis
promoter [137].
As expected from the pattern of Fis concentration in the cell, there is a
negative relationship between the intracellular level of RpoS and Fis during
stationary phase growth [140]. Fis in fact is able to mediate expression from a s dependent genes by binding to a Fis-specific site upstream of as promoter regions
and blocking RpoS activity during exponential growth [59].
Fis, as its name suggests, is also essential for the ability of Salmonella to
switch flagellar types. There are two types of flagellar filaments, FljB and FliC,
which are both transcribed from class 3 promoters. Flagellar switching is achieved
by inversion of a promoter region. When expression occurs from this promoter, a
type B filament is produced and a repressor of type C is created. When the inversion
occurs, the repressor of type C is not produced and type C filaments are made [140].
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Hin (for H invertase) and Fis are both required for proper inversion [141]. Hin
seems to mediate the inversion while Fis ensures the appropriate alignment of the
piece of DNA that is being inverted [141].
In having two different types of filaments available for use, Salmonella is able
to evade the host immune system. FliC is a well-studied target ofthe immune
system [91]. As bacteria migrate through the small intestines and into the rest of
the host, FliC expression is suppressed or switched for FljB expression to avoid
detection by T cells [91]. Once past the initial site of infection, T cells are no longer
able to recognize the pathogen [91]. Fis allows for the switching of promoter
availability to FliA and due to its pattern of concentration in the cell, ensures that
the bacteria is not wasting cellular energy making flagella while in stationary
growth.
Finally, the relatedness of alternate sigma factors and pathogenicity can
ensure that certain genes are not expressed at the wrong time. The gene hilA which
is responsible for the regulation of SPI -1 genes is found in the same operon as FliA,
the alternate sigma factor for flagellar filament assembly [87]. This proximity
within the genome allows for the simultaneous control of both mobility and
invasion properties.

15. From Theory to Practice
Differential gene expression through the use of alternate sigma factors is one
of numerous regulatory methods available to Salmonella to avoid destruction by its
host's immune system or sanitation processes and to thrive in a variety of
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environments. Control through sigma factors intersects control exerted by other
regulatory pathways to ensure a highly controllable pattern of gene expression.
There is yet much more work to be done in this area. The full capacity of
Salmonella to change rapidly and accurately to respond to environmental conditions
is still not well understood. Genes that are central to virulence are often under the
most types of regulatory control. For example, sigma factor expression is itself is
highly controlled at the level oftranscription and translation, but they are
interconnected in a complex web, regulating and fine tuning the gene expression
from each type of promoter.
The use of alternate sigma factors seems to be a specific evolutionary tactic
for Salmonella to survive in the environment and inside a host. The differential gene
expression that Salmonella demonstrates is induced by environmental conditions
that the pathogen encounters within its hosts. Moreover, these environmental
conditions are in a constant state of flux, as a product of the bacteria's movement
through its host as well as the changing state of the host itself. It is not clear the
extent of signals that induce the differential gene expression in Salmonella.
Sensitivities and properties that Salmonella demonstrates outside of a host may be
quite different from what happens inside another organism. While there is no
evidence that differential gene expression through alternate sigma factors confers
antibiotic resistance, it is likely that the adaptive manner in which Salmonella is able
to survive within its host will affect its interaction with other bacteria grown in the
same system and the ability of the antibiotic to act on the bacteria by allowing it to
change phases of growth rapidly as a population.
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